Details of the Researcher

PHOTO

Yoshiro Saito
Section
Graduate School of Pharmaceutical Sciences
Job title
Professor
Degree
  • 博士(薬学)(北海道大学)

  • 修士(薬学)(北海道大学)

e-Rad No.
70357060
Researcher ID

Research History 12

  • 2022/12 - Present
    Chiba University Graduate School of Pharmaceutical Sciences

  • 2018/09 - Present
    東北大学大学院 薬学研究科 教授

  • 2020/10 - 2025/03
    University of Tokyo Graduate School of Agricultural and Life Sciences part-time lecturer

  • 2018/04 - 2018/08
    Doshisha University Faculty of Life and Medical Sciences

  • 2012/04 - 2018/03
    Doshisha University Faculty of Life and Medical Sciences

  • 2008/04 - 2012/03
    Doshisha University Faculty of Life and Medical Sciences Lecturer

  • 2007/04 - 2008/03
    AIST

  • 2007 - 2008
    Research Scientist for Human Stress Signal Research Center, National

  • 2002/04 - 2007/03
    産業技術総合研究所 ヒューマンストレスシグナル研究センター 若手任期付研究員

  • 2002 - 2007
    Research Scientist for Human Stress Signal Research Center, National

  • 2000/01 - 2002/03
    日本学術振興会 北海道大学大学院薬学研究科 特別研究員DC2

  • 2001 - 2002
    Postdoctoral Research Fellow of the Japan Society for the Promotion of Science

Show all Show first 5

Education 3

  • 北海道大学大学院 薬学研究科 創薬化学専攻

    1998/04 - 2001/03

  • 北海道大学大学院 薬学研究科 薬学専攻

    1996/04 - 1998/03

  • Hokkaido University Faculty of Pharmaceutical Sciences

    1991/04 - 1996/03

Committee Memberships 15

  • レドックスR&D戦略委員会 委員長

    2025/04 - Present

  • 日本微量元素学会 理事

    2025/04 - Present

  • 日本生化学会 代議員

    2024/04 - Present

  • 日本酸化ストレス学会 理事

    2024/04 - Present

  • Japan Society for Biomedical Research on Trace Elements delegate

    2023/08 - Present

  • Redox Experimental Medicine Editorial Board

    2022/04 - Present

  • Japanese Society of Toxicology councilor

    2021/07 - Present

  • Free Radical Biology & Medicine Editorial Board

    2020/05 - Present

  • Journal of Clinical Biochemistry and Nutrition Executive Editor

    2020/01 - Present

  • Free Radical Research Editorial Board

    2019/02 - Present

  • 日本薬学会 代議員

    2019/02 - Present

  • 日本脂質生化学会 幹事

    2019/01 - Present

  • 日本毒性学会生体金属部会 幹事

    2018/11 - Present

  • ビタミンE研究会 幹事

    2017/04 - Present

  • 日本酸化ストレス学会 代議員

    2014/04 - Present

Show all ︎Show first 5

Professional Memberships 8

  • レドックスR&D戦略委員会

    - Present

  • 日本毒性学会

    - Present

  • 日本微量元素学会

    - Present

  • 日本酸化ストレス学会

  • 日本薬学会

  • 日本ビタミン学会

  • 日本生化学会

  • The Japanese Biochemical Society

︎Show all ︎Show first 5

Research Interests 10

  • Neurodegenerative disease

  • Diabetes

  • Biomarker

  • セレノプロテイン

  • 細胞死

  • ストレス応答

  • 酸化ストレス

  • Cell death

  • Stress Response

  • Oxidative Stress

Research Areas 2

  • Life sciences / Pharmacology /

  • Life sciences / Pharmaceuticals - health and biochemistry /

Awards 17

  1. High Citation Award

    2023/05 (SFRR-Japan)

  2. Investigator Award

    2021/03 (SFRR-International)

  3. 学術賞(日本酸化ストレス学会)

    2018

  4. International Prize (SFRR-International)

    2018

  5. 学術奨励賞 ( 日本酸化ストレス学会 )

    2012

  6. Young Investigator Award ( SFRR-JAPAN )

    2012

  7. One of Elsevier's Top 10 Cited Articles on Scopus 2007-2008 in NeuroToxicology

    2010

  8. 学術奨励賞 ( ビタミンE研究会 )

    2009

  9. 学術奨励賞 ( 日本フリーラジカル学会 / 日本過酸化脂質フリーラジカル学会 )

    2007

  10. Young Investigator Award ( SFRR-Japan )

    2007

  11. Young Investigator Award ( SFRR-Asia )

    2005

  12. Travel Grant for Young Scientists ( International Interdisciplinary Conference on Vitamins, Coenzymes, and Biofactors 2005 )

    2005

  13. Young Investigator Award ( SFRR-Asia )

    2005

  14. Travel Grant for Young Scientists ( International Interdisciplinary Conference on Vitamins, Coenzymes, and Biofactors 2005 )

    2005

  15. Fellowship Award ( A New York Academy of Sciences Conference Vitamin E and Health )

    2004

  16. Fellowship Award ( A New York Academy of Sciences Conference Vitamin E and Health )

    2004

  17. Prize for Emcouragement (Antioxidant Biofactor Research Society)

    2004

Show all ︎Show 5

Papers 180

  1. Gender differences in plasma element concentrations and associations between selenoprotein P and iron metabolism in a community-based cohort study. International-journal

    Yoshiro Saito, Misaki Shimizu, Mitsuharu Sato, An Masuda, Kotoko Arisawa, Keiko Taguchi, Takashi Toyama, Ikuko N Motoike, Kengo Kinoshita, Seizo Koshiba, Masayuki Yamamoto, Toshinari Takamura

    Scientific reports 15 (1) 25319-25319 2025/07/13

    DOI: 10.1038/s41598-025-10581-2  

    More details Close

    Essential trace elements, such as iron (Fe) and selenium (Se), play physiological roles in our body, whereas environmental toxic metals, such as arsenic (As), cadmium (Cd), and mercury (Hg), are known to be associated with various disease risks. However, the relationship between elements, biochemical parameters, and lifestyle habits based on multi-elemental analysis in healthy individuals has not been fully verified. Multi-elemental analysis is useful for evaluating the change in the concentration of these elements and metals. In the present study using totally 100 µL plasma samples from the Tohoku Medical Megabank (TMM) community-based cohort study (total of 506 specimens), we conducted a multi-elemental analysis to evaluate 14 elements in generally healthy subjects. We further determined Se-transporter selenoprotein P levels using the originally developed ELISA method, since increases and decreases in selenoprotein P levels are associated with various disease risks. Multiple correlation analyses between the obtained measured values and several factors suggest that elements such as Fe, Se, and Hg, as well as selenoprotein P levels, are associated with gender differences. We also found that factors such as Fe, Se, As, Hg, hematocrit value, hemoglobin (Hb) content, and HbA1c are correlated with selenoprotein P levels. Furthermore, correlations between Fe levels and Hb content and between As/Hg and fish consumption were found. These findings demonstrate the suitability of multi-elemental analyses with limited plasma sample amounts, clearly show gender-differentiated elements, and establish a significant relationship between selenoprotein P and Fe metabolism.

  2. Lactoferrin attenuates renal fibrosis and uremic sarcopenia in a mouse model of adenine-induced chronic kidney disease

    Yukina Iwamoto, Seiko Yamakoshi, Akiyo Sekimoto, Koji Hosomi, Takashi Toyama, Yoshiro Saito, Jun Kunisawa, Nobuyuki Takahashi, Eikan Mishima, Emiko Sato

    The Journal of Nutritional Biochemistry 2025/07

    DOI: 10.1016/j.jnutbio.2025.110039  

  3. The selenoprotein P/ApoER2 axis facilitates selenium accumulation in selenoprotein P-accepting cells and confers prolonged resistance to ferroptosis. International-journal

    Atsuya Ichikawa, Takashi Toyama, Hiroki Taguchi, Satoru Shiina, Hayato Takashima, Kazuaki Takahashi, Yasumitsu Ogra, Ayako Mizuno, Kotoko Arisawa, Yoshiro Saito

    Redox biology 83 103664-103664 2025/06

    DOI: 10.1016/j.redox.2025.103664  

    More details Close

    The essential trace element selenium (Se) plays a significant role in redox homeostasis, while Se is very reactive and has a potent toxicity. Understanding the molecular machinery that supports Se metabolism is important for the both physiological and pathophysiological context. Incorporated Se is translated/transformed in the liver into selenoprotein P (SeP; encoded by Selenop), an extracellular Se carrier protein that effectively transports Se to the cells via the binding to its receptor apolipoprotein E receptor 2 (ApoER2), which is taken up by cells. The present study shows that SeP is a source of Se that accumulates intracellularly and can be utilized for prolonged periods under Se-deficient conditions. In cultured cells (RD and SH-SY5Y), glutathione peroxidase (GPX) expression induced by Se supply via the SeP/ApoER2 pathway was maintained longer during Se deficiency than inorganic Se, which was promoted by ApoER2 overexpression. SeP-deficient mice showed a faster decline in brain Se levels when fed a Se-deficient diet. Preserved GPX expression induced by this SeP/ApoER2 axis contributed to oxidative stress and ferroptosis resistance, suggesting that this redundant Se metabolism contributes to prolonged Se utilization and cytoprotection.

  4. Lipid peroxidation, ferroptosis, and antioxidants. International-journal

    Noriko Noguchi, Yoshiro Saito, Etsuo Niki

    Free radical biology & medicine 237 228-238 2025/05/13

    DOI: 10.1016/j.freeradbiomed.2025.05.393  

    More details Close

    The discovery and conceptualization of ferroptosis as regulated, iron-catalyzed cell death driven by excessive lipid peroxidation triggered re-evaluation of lipid hydroperoxides in connection with health and disease. Free and ester forms of polyunsaturated fatty acids (PUFAs) are oxidized in vivo by multiple oxidizing species to produce lipid hydroperoxides as primary products, some purposely while others unintentionally. The detailed analysis of isomer distribution of lipid hydroperoxides enables us to identify the responsible oxidants. Linoleates, the most abundant PUFA in humans, are oxidized to give multiple isomers of hydroperoxyoctadecadienoates (H(p)ODEs) as primary major products, racemic trans, trans-9- and 13-H(p)ODEs, 13(S)-cis, trans-H(p)ODE, and 10- and 12-H(p)ODEs being specific biomarker for the oxidation by free radicals, lipoxygenase (LOX), and singlet oxygen, respectively. Cholesterol is another important lipid and its hydroperoxides are produced solely by non-enzymatic oxidation, the major products being cholesterol 7-hydroperoxide and 5-hydroperoxide by free radicals and singlet oxygen, respectively. The available data obtained from human samples show that lipid hydroperoxides are produced in vivo primarily by free radical mediated lipid peroxidation and that the contribution of LOXs and singlet oxygen is small. Multiple antioxidants having different functions play their respective roles in the physiological defense network against detrimental lipid peroxidation and ferroptosis. The fact that lipid hydroperoxides are produced in vivo mainly by free radical mediated lipid peroxidation suggests that radical scavenging antioxidants act as essential ferroptosis inhibitors, which was substantiated by many studies. Considering the reactivity and physiological concentrations, it may be said that vitamins E and C play the primary roles as biological radical scavenging antioxidants against ferroptosis by synergistic interactions. Novel synthetic antioxidants with higher reactivity than natural antioxidants have been reported and their biological effects should be assessed. The factors that determine antioxidant effects in vivo are critically reviewed.

  5. Cysteine redoxome landscape in mouse brown adipose tissue under acute cold exposure. International-journal

    Hein Ko Oo, Cynthia M Galicia-Medina, Takumi Nishiuchi, Ryota Tanida, Hisanori Goto, Yujiro Nakano, Yumie Takeshita, Yoshiro Saito, Hiroaki Takayama, Toshinari Takamura

    iScience 28 (3) 112051-112051 2025/03/21

    DOI: 10.1016/j.isci.2025.112051  

    More details Close

    Reversible cysteine post-translational modifications serve as a "switch" for protein structure-function dynamics. While reversible cysteine oxidation in uncoupling protein 1 is known to play a role in brown fat thermogenesis, the full cysteine redoxome affected by cold exposure remains unexplored. We established a strategy for comprehensively mapping the cysteine redoxome by pinpointing oxidized and reduced cysteine residues in the brown adipose tissue of mice under room temperature and acute cold exposure. We identified over 1,000 labeled cysteine residues under room and cold temperatures. Cold exposure shifted the cysteine redox states toward oxidation. Cold-sensitive reactive cysteine residues were enriched in biological processes and molecular functions associated with thermogenesis pathways. The presence of proximal positively charged and negatively charged amino acids determined the highly reactive and non-reactive cysteine residues, respectively, under cold exposure. Our findings broaden the landscape of cold-sensitive proteome and identify potential therapeutic targets to fine-tune thermogenesis.

  6. Assessing the role of selenium in Minamata disease through reanalysis of historical samples. International-journal

    Mineshi Sakamoto, Masumi Marumoto, Koichi Haraguchi, Takashi Toyama, Yoshiro Saito, Steven J Balogh, Chiharu Tohyama, Masaaki Nakamura

    Environment international 195 109242-109242 2025/01

    DOI: 10.1016/j.envint.2024.109242  

    More details Close

    Minamata disease, a severe neurological disorder identified in Japan in 1956, results from methylmercury (MeHg) intoxication in humans due to environmental contamination. Before MeHg was recognized as the cause, selenium (Se) was suspected of being the potential cause owing to elevated Se levels in patients' organs. Subsequent animal studies indicated that Se mitigates MeHg toxicity; however, its role in Minamata disease remains unexplored. We analyzed Hg and Se in historical samples of the industrial wastes (n = 4) on the factory site, sediments (n = 9), and fish/shellfish (n = 16) in Minamata Bay, and organs of patients with Minamata disease (n = 12). All samples showed elevated levels of both Hg and Se, providing the first evidence that Se was also discharged into Minamata Bay, entering the food chain and accumulating at high levels in patient organs. The Hg/Se molar ratio in contaminated shellfish (median > 3.0) indicated exceptionally high MeHg exposure, far exceeding the ordinary level (< 1.0). Patients exhibited significantly increased Se levels in the liver and kidney but lower amounts in the brain. Notably, median Hg/Se molar ratios exceeding 4.0 were observed, particularly in the cerebrum and cerebellum in acute cases, closely mirroring the molar ratios found in seafood. The elevated Hg/Se molar ratio in the brain helps explain the severe neurological damage in patients' central nervous systems, despite higher Hg levels in the liver and kidney compared to the brain. These findings provide important insight into the mechanism of MeHg intoxication and highlight the risks associated with MeHg-contaminated seafood, aiding efforts to protect consumers.

  7. Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria. International-journal

    Yusuke Hirata, Yuto Yamada, Soma Taguchi, Ryota Kojima, Haruka Masumoto, Shinnosuke Kimura, Takuya Niijima, Takashi Toyama, Ryoji Kise, Emiko Sato, Yasunori Uchida, Junya Ito, Kiyotaka Nakagawa, Tomohiko Taguchi, Asuka Inoue, Yoshiro Saito, Takuya Noguchi, Atsushi Matsuzawa

    Cell death & disease 15 (12) 884-884 2024/12/06

    DOI: 10.1038/s41419-024-07237-w  

    More details Close

    Conjugated fatty acids (CFAs) have been known for their anti-tumor activity. However, the mechanism of action remains unclear. Here, we identify CFAs as inducers of glutathione peroxidase 4 (GPX4) degradation through chaperone-mediated autophagy (CMA). CFAs, such as (10E,12Z)-octadecadienoic acid and α-eleostearic acid (ESA), induced GPX4 degradation, generation of mitochondrial reactive oxygen species (ROS) and lipid peroxides, and ultimately ferroptosis in cancer cell lines, including HT1080 and A549 cells, which were suppressed by either pharmacological blockade of CMA or genetic deletion of LAMP2A, a crucial molecule for CMA. Mitochondrial ROS were sufficient and necessary for CMA-dependent GPX4 degradation. Oral administration of an ESA-rich oil attenuated xenograft tumor growth of wild-type, but not that of LAMP2A-deficient HT1080 cells, accompanied by increased lipid peroxidation, GPX4 degradation and cell death. Our study establishes mitochondria as the key target of CFAs to trigger lipid peroxidation and GPX4 degradation, providing insight into ferroptosis-based cancer therapy.

  8. Modifications of DJ-1 in which pI shifts to acidic in red blood cells a potential biomarker for Parkinson's disease at early stages. International-journal

    Kohei Matsuda, Yuichiro Mita, Kazumasa Saigoh, Yoshiro Saito, Noriko Noguchi

    Free radical research 58 (11) 1-10 2024/11/22

    DOI: 10.1080/10715762.2024.2430536  

    More details Close

    Parkinson's disease (PD) is one of the most common neurodegenerative diseases, the incidence of which increases with age. However, since there is no fundamental treatment or methods for early diagnosis, new methods of treatment and diagnosis are urgently needed. We focused on post-translational modifications of DJ-1, which is encoded by the familial PD-causative gene PARK7 in red blood cells (RBCs). DJ-1 has three cysteines (Cys46, Cys53, and Cys106), with Cys106 being preferentially oxidized. We previously reported that sulfinated/sulfonated Cys106 DJ-1 (oxDJ-1) is increased in the RBCs of PD patients. In this study, we analyzed RBC-derived DJ-1 from PD patients and control subjects by 2-dimensional electrophoresis. We found that the ratio of the spot of DJ-1 with a more acidic isoelectric point than oxDJ-1 was increased more significantly than that of oxDJ-1 in RBCs from patients at the early stage of unmedicated PD and decreased with the progression of PD stage and treatment. Furthermore, we revealed that this acidic spot of DJ-1 increased upon exposure to H2O2. However, when either Cys53 or Cys106 of DJ-1 was replaced with serine, there was no significant increase in the acidic spot caused by H2O2. In this study, we propose a new biomarker for early diagnosis of PD using both the ratios of oxDJ-1 to total DJ-1 and the acidic spot of DJ-1 to total DJ-1.

  9. Remodeling of Selenium Metabolism through Adduct Formation of Selenoprotein P with Epigallocatechin Gallate Peer-reviewed

    Takashi Toyama, Katsuki Sato, Yoshiro Saito

    Metallomics Research 4 (3) 1-6 2024/11

    DOI: 10.11299/metallomicsresearch.MR202403  

  10. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization

    Junya Ito, Toshitaka Nakamura, Takashi Toyama, Deng Chen, Carsten Berndt, Gereon Poschmann, André Santos Dias Mourão, Sebastian Doll, Mirai Suzuki, Weijia Zhang, Jiashuo Zheng, Dietrich Trümbach, Naoya Yamada, Koya Ono, Masana Yazaki, Yasutaka Kawai, Mieko Arisawa, Yusuke Ohsaki, Hitoshi Shirakawa, Adam Wahida, Bettina Proneth, Yoshiro Saito, Kiyotaka Nakagawa, Eikan Mishima, Marcus Conrad

    Molecular Cell 2024/11

    Publisher: Elsevier BV

    DOI: 10.1016/j.molcel.2024.10.028  

    ISSN: 1097-2765

  11. Inhibition of Selenium Supply Function of Selenoprotein P through Adduct Formation by Sulforaphane. International-journal

    Xinying Ye, Takashi Toyama, Wang Yinuo, Runa Kudo, Siu Stephanie, Kotoko Arisawa, Yoshiro Saito

    The Journal of nutritional biochemistry 135 109781-109781 2024/10/15

    DOI: 10.1016/j.jnutbio.2024.109781  

    More details Close

    Selenium is a potent nucleophile essential for selenoenzymes, such as glutathione peroxidase (also known as GSH-Px; GPX; GPx) and selenoprotein P (also known as SelP; SEPP1; SELENOP; SeP). SeP is predominantly secreted from the liver and functions as a selenium carrier in plasma. We previously found that sulforaphane, an electrophilic phytochemical, reduces SeP production in cultured hepatocytes and mouse liver, however, the effect of electrophilic modification of SeP by SFN on selenium transport and metabolism remains unclear. In the present study, we demonstrate that sulforaphane covalently modifies selenocysteine/cysteine residues of SeP using an acidic biotin PAEC5 maleimide labeling assay, which allows for focused-labeling of selenocysteine residues. Although the SFN-SeP adduct can be taken up by HepG2 cells and degraded by the lysosome, it was less effective in inducing GPx expression. Our findings indicate that SFN disrupts the selenium supply pathway through the formation of the SeP-SFN adduct.

  12. Differential associations between selenoprotein P and distal sensorimotor polyneuropathy in people with and without diabetes: KORA F4/FF4 study International-journal

    Christian Herder, Yoshiro Saito, Maria C. Spagnuolo, Haifa Maalmi, Misaki Shimizu, Gidon J. Bönhof, Keita Suzuki, Wolfgang Rathmann, Annette Peters, Michael Roden, Dan Ziegler, Barbara Thorand, Toshinari Takamura

    Free Radical Biology and Medicine 223 87-95 2024/10

    Publisher: Elsevier BV

    DOI: 10.1016/j.freeradbiomed.2024.07.028  

    ISSN: 0891-5849

    More details Close

    BACKGROUND: Oxidative stress is a risk factor for distal sensorimotor polyneuropathy (DSPN). Selenoprotein P is a protein with antioxidant properties but has not been investigated in the context of DSPN. This study aimed to assess the associations between selenoprotein P and DSPN in people without and with type 2 diabetes (T2D). METHODS: Cross-sectional and prospective analyses were based on 1053 (including 217 with T2D) and 513 participants (including 79 with T2D), respectively, aged 61-82 years from the population-based KORA F4 survey. DSPN at baseline (KORA F4) and in the follow-up survey KORA FF4 was defined based on the Michigan Neuropathy Screening Instrument. Serum levels of full-length selenoprotein P were quantified by ELISA. Associations between selenoprotein P and prevalent or incident DSPN were estimated using logistic regression analysis adjusting for multiple confounders. RESULTS: Selenoprotein P levels were not associated with prevalent DSPN in the total sample. However, there was a significant interaction by diabetes status. Higher levels of selenoprotein P were associated with lower odds of prevalent DSPN in individuals without T2D (fully adjusted model: OR 0.825 [95 % CI 0.682, 0.998], p = 0.0476), but not in those with T2D (OR [95 % CI] 1.098 [0.829, 1.454], p = 0.5132; pinteraction = 0.0488). Selenoprotein P levels were not associated with incident DSPN over a follow-up of 6.5 years. CONCLUSION: In individuals without T2D from the older general population, lower selenoprotein P levels were associated with a higher prevalence of DSPN. Whether the antioxidant properties of selenoprotein P are responsible for the observed associations remains to be elucidated in future research.

  13. Ferroptosis in health and disease. International-journal

    Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, Scott Ayton, Uladzimir Barayeu, Alexander Bartelt, Hülya Bayir, Christina M Bebber, Kivanc Birsoy, Jan P Böttcher, Simone Brabletz, Thomas Brabletz, Ashley R Brown, Bernhard Brüne, Giorgia Bulli, Alix Bruneau, Quan Chen, Gina M DeNicola, Tobias P Dick, Ayelén Distéfano, Scott J Dixon, Jan B Engler, Julia Esser-von Bieren, Maria Fedorova, José Pedro Friedmann Angeli, Manuel A Friese, Dominic C Fuhrmann, Ana J García-Sáez, Karolina Garbowicz, Magdalena Götz, Wei Gu, Linda Hammerich, Behrouz Hassannia, Xuejun Jiang, Aicha Jeridi, Yun Pyo Kang, Valerian E Kagan, David B Konrad, Stefan Kotschi, Peng Lei, Marlène Le Tertre, Sima Lev, Deguang Liang, Andreas Linkermann, Carolin Lohr, Svenja Lorenz, Tom Luedde, Axel Methner, Bernhard Michalke, Anna V Milton, Junxia Min, Eikan Mishima, Sebastian Müller, Hozumi Motohashi, Martina U Muckenthaler, Shohei Murakami, James A Olzmann, Gabriela Pagnussat, Zijan Pan, Thales Papagiannakopoulos, Lohans Pedrera Puentes, Derek A Pratt, Bettina Proneth, Lukas Ramsauer, Raphael Rodriguez, Yoshiro Saito, Felix Schmidt, Carina Schmitt, Almut Schulze, Annemarie Schwab, Anna Schwantes, Mariluz Soula, Benedikt Spitzlberger, Brent R Stockwell, Leonie Thewes, Oliver Thorn-Seshold, Shinya Toyokuni, Wulf Tonnus, Andreas Trumpp, Peter Vandenabeele, Tom Vanden Berghe, Vivek Venkataramani, Felix C E Vogel, Silvia von Karstedt, Fudi Wang, Frank Westermann, Chantal Wientjens, Christoph Wilhelm, Michele Wölk, Katherine Wu, Xin Yang, Fan Yu, Yilong Zou, Marcus Conrad

    Redox biology 75 103211-103211 2024/09

    DOI: 10.1016/j.redox.2024.103211  

    More details Close

    Ferroptosis is a pervasive non-apoptotic form of cell death highly relevant in various degenerative diseases and malignancies. The hallmark of ferroptosis is uncontrolled and overwhelming peroxidation of polyunsaturated fatty acids contained in membrane phospholipids, which eventually leads to rupture of the plasma membrane. Ferroptosis is unique in that it is essentially a spontaneous, uncatalyzed chemical process based on perturbed iron and redox homeostasis contributing to the cell death process, but that it is nonetheless modulated by many metabolic nodes that impinge on the cells' susceptibility to ferroptosis. Among the various nodes affecting ferroptosis sensitivity, several have emerged as promising candidates for pharmacological intervention, rendering ferroptosis-related proteins attractive targets for the treatment of numerous currently incurable diseases. Herein, the current members of a Germany-wide research consortium focusing on ferroptosis research, as well as key external experts in ferroptosis who have made seminal contributions to this rapidly growing and exciting field of research, have gathered to provide a comprehensive, state-of-the-art review on ferroptosis. Specific topics include: basic mechanisms, in vivo relevance, specialized methodologies, chemical and pharmacological tools, and the potential contribution of ferroptosis to disease etiopathology and progression. We hope that this article will not only provide established scientists and newcomers to the field with an overview of the multiple facets of ferroptosis, but also encourage additional efforts to characterize further molecular pathways modulating ferroptosis, with the ultimate goal to develop novel pharmacotherapies to tackle the various diseases associated with - or caused by - ferroptosis.

  14. Endocytic vesicles act as vehicles for glucose uptake in response to growth factor stimulation International-journal

    Ryouhei Tsutsumi, Beatrix Ueberheide, Feng-Xia Liang, Benjamin G. Neel, Ryuichi Sakai, Yoshiro Saito

    Nature Communications 15 (1) 2843-2843 2024/04/02

    DOI: 10.1038/s41467-024-46971-9  

    More details Close

    Glycolysis is a fundamental cellular process, yet its regulatory mechanisms remain incompletely understood. Here, we show that a subset of glucose transporter 1 (GLUT1/SLC2A1) co-endocytoses with platelet-derived growth factor (PDGF) receptor (PDGFR) upon PDGF-stimulation. Furthermore, multiple glycolytic enzymes localize to these endocytosed PDGFR/GLUT1-containing vesicles adjacent to mitochondria. Contrary to current models, which emphasize the importance of glucose transporters on the cell surface, we find that PDGF-stimulated glucose uptake depends on receptor/transporter endocytosis. Our results suggest that growth factors generate glucose-loaded endocytic vesicles that deliver glucose to the glycolytic machinery in proximity to mitochondria, and argue for a new layer of regulation for glycolytic control governed by cellular membrane dynamics.

  15. Cholesterol is more readily oxidized than phospholipid linoleates in cell membranes to produce cholesterol hydroperoxides

    Yoshiro Saito, Noriko Noguchi, Etsuo Niki

    Free Radical Biology and Medicine 2024/02

    DOI: 10.1016/j.freeradbiomed.2023.12.011  

  16. Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage International-journal

    Xi Zheng, Takashi Toyama, Stephanie Siu, Takayuki Kaneko, Hikari Sugiura, Shota Yamashita, Yoshiteru Shimoda, Masayuki Kanamori, Kotoko Arisawa, Hidenori Endo, Yoshiro Saito

    Scientific Reports 14 (1) 682-682 2024/01/05

    Publisher: Springer Science and Business Media LLC

    DOI: 10.1038/s41598-024-51259-5  

    eISSN: 2045-2322

    More details Close

    Abstract Glioblastoma (GBM) is one of the most aggressive and deadly brain tumors; however, its current therapeutic strategies are limited. Selenoprotein P (SeP; SELENOP, encoded by the SELENOP gene) is a unique selenium-containing protein that exhibits high expression levels in astroglia. SeP is thought to be associated with ferroptosis sensitivity through the induction of glutathione peroxidase 4 (GPX4) via selenium supplementation. In this study, to elucidate the role of SeP in GBM, we analyzed its expression in GBM patients and found that SeP expression levels were significantly higher when compared to healthy subjects. Knock down of SeP in cultured GBM cells resulted in a decrease in GPX1 and GPX4 protein levels. Under the same conditions, cell death caused by RSL3, a ferroptosis inducer, was enhanced, however this enhancement was canceled by supplementation of selenite. These results indicate that SeP expression contributes to preserving GPX and selenium levels in an autocrine/paracrine manner, i.e., SeP regulates a dynamic cycling-selenium storage system in GBM. We also confirmed the role of SeP expression in ferroptosis sensitivity using patient-derived primary GBM cells. These findings indicate that expression of SeP in GBM can be a significant therapeutic target to overcome anticancer drug resistance.

  17. Impact of selenium content in fetal bovine serum on ferroptosis susceptibility and selenoprotein expression in cultured cells.

    Hayato Takashima, Takashi Toyama, Eikan Mishima, Kei Ishida, Yinuo Wang, Atsuya Ichikawa, Junya Ito, Syunsuke Yogiashi, Stephanie Siu, Mayumi Sugawara, Satoru Shiina, Kotoko Arisawa, Marcus Conrad, Yoshiro Saito

    The Journal of toxicological sciences 49 (12) 555-563 2024

    DOI: 10.2131/jts.49.555  

    More details Close

    Ferroptosis, a mode of cell death involving iron-dependent lipid peroxidation, has attracted widespread attention in the development of anticancer drugs and toxicological studies as a potential mechanism of chemical-induced cytotoxicity. This process is regulated by several antioxidant enzymes, of which the selenium-containing glutathione peroxidase 4 (GPx4) is the prime regulator. However, accurately and reproducibly evaluating ferroptosis in cultured cells is challenging since numerous experimental factors in in vitro setting can influence the results. In the present study, we found that the expression levels of selenoproteins, such as GPx4 and GPx1, fluctuate across several cell lines depending on the selenium content of different origin of fetal bovine serum (FBS). Cells cultured in FBS containing higher selenium concentrations exhibited elevated GPx4 expression, and were resistant to ferroptosis induced by erastin and RSL3. These findings suggest that the variability of selenium content in different FBS batches can significantly influence the susceptibility of cells to ferroptosis, highlighting the importance of standardizing these factors to enhance the reproducibility of ferroptosis-related experiments.

  18. Ccdc152 is not necessary for male fertility, but contributes to maintaining sperm morphology

    Ryua HARIMA, Takahiro SASAKI, Takayuki KANEKO, Fuka ASO, Hayato TAKASHIMA, Takashi TOYAMA, Kenshiro HARA, Kentaro TANEMURA, Yoshiro SAITO

    Journal of Reproduction and Development 70 (6) 396-404 2024

    Publisher: Japanese Society of Animal Reproduction

    DOI: 10.1262/jrd.2024-058  

    ISSN: 0916-8818

    eISSN: 1348-4400

    More details Close

    Selenoprotein P (SeP) is synthesized in the liver and plays a vital role in maintaining selenium homeostasis via transport throughout the body. Previous studies have shown that SeP-deficient mice have severely reduced expression of selenoproteins essential for testicular function, leading to male infertility. We previously reported that the high expression of Ccdc152 in hepatocytes acts as a lncRNA, suppressing SeP expression in the liver. Ccdc152 reduces SeP translation by binding to SeP mRNA and decreasing its interaction with SECIS-binding protein 2. Although Ccdc152 is highly expressed in testes, its function remains unclear. Therefore, this study aimed to elucidate the role of Ccdc152 in the testes. Using the CRISPR/Cas9 system, we generated mice lacking all exons of Ccdc152 and found that SeP expression levels in the liver and plasma, as well as overall selenium homeostasis, remained unchanged. No significant differences were observed in the expression of glutathione peroxidase 1/4 or level of selenium in the testes. Subsequent investigation of the impact on male reproductive function revealed no abnormalities in sperm motility or Mendelian ratios of the offspring. However, a slight decrease in testicular weight and an increased rate of sperm malformations in the epididymis were observed. RNA-seq and pathway analyses identified the reduced expression of multiple genes related to kinesin and reproductive pathways. Based on these findings, Ccdc152 may not be essential for male reproductive function, but it may enhance reproductive capabilities by maintaining the expression of genes necessary for reproduction.

  19. メチル水銀の解毒代謝におけるグルタチオンと超硫黄の異なる役割

    Takashi Toyama, Runa Kudo, Yoshiro Saito

    YAKUGAKU ZASSHI 144 (1) 41-45 2024/01/01

    Publisher: Pharmaceutical Society of Japan

    DOI: 10.1248/yakushi.23-00162-1  

    ISSN: 0031-6903

    eISSN: 1347-5231

  20. Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2

    Xinying Ye, Takashi Toyama, Keiko Taguchi, Kotoko Arisawa, Takayuki Kaneko, Ryouhei Tsutsumi, Masayuki Yamamoto, Yoshiro Saito

    Communications Biology 6 (1) 2023/10/19

    Publisher: Springer Science and Business Media LLC

    DOI: 10.1038/s42003-023-05449-y  

    eISSN: 2399-3642

    More details Close

    Abstract Selenoprotein P (SeP) is a major selenoprotein in serum predominantly produced in the liver. Excess SeP impairs insulin secretion from the pancreas and insulin sensitivity in skeletal muscle, thus inhibition of SeP could be a therapeutic strategy for type 2 diabetes. In this study, we examine the effect of sulforaphane (SFN), a phytochemical of broccoli sprouts and an Nrf2 activator, on SeP expression in vitro and in vivo. Treatment of HepG2 cells with SFN decreases inter- and intra-cellular SeP levels. SFN enhances lysosomal acidification and expression of V-ATPase, and inhibition of this process cancels the decrease of SeP by SFN. SFN activates Nrf2 in the cells, while Nrf2 siRNA does not affect the decrease of SeP by SFN or lysosomal acidification. These results indicate that SFN decreases SeP by enhancing lysosomal degradation, independent of Nrf2. Injection of SFN to mice results in induction of cathepsin and a decrease of SeP in serum. The findings from this study are expected to contribute to developing SeP inhibitors in the future, thereby contributing to treating and preventing diseases related to increased SeP.

  21. An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase

    Ayako Mizuno, Takashi Toyama, Atsuya Ichikawa, Naoko Sakai, Yuya Yoshioka, Yukina Nishito, Renya Toga, Hiroshi Amesaka, Takayuki Kaneko, Kotoko Arisawa, Ryouhei Tsutsumi, Yuichiro Mita, Shun-ichi Tanaka, Noriko Noguchi, Yoshiro Saito

    Journal of Biological Chemistry 299 (8) 105009-105009 2023/07

    Publisher: Elsevier BV

    DOI: 10.1016/j.jbc.2023.105009  

    ISSN: 0021-9258

  22. Selenoprotein P concentrations and risk of progression from mild cognitive impairment to dementia. International-journal

    Marco Vinceti, Teresa Urbano, Annalisa Chiari, Tommaso Filippini, Lauren A Wise, Manuela Tondelli, Bernhard Michalke, Misaki Shimizu, Yoshiro Saito

    Scientific reports 13 (1) 8792-8792 2023/05/31

    DOI: 10.1038/s41598-023-36084-6  

    More details Close

    There is a growing literature investigating the effects of selenium on the central nervous system and cognitive function. However, little is known about the role of selenoprotein P, the main selenium transporter, which can also have adverse biological effects. We conducted a prospective cohort study of individuals aged 42-81 years who received a clinical diagnosis of mild cognitive impairment. Using sandwich ELISA methods, we measured full-length selenoprotein P concentrations in serum and cerebrospinal fluid to assess the relation with dementia incidence during a median follow-up of 47.3 months. We used Cox proportional hazards regression and restricted cubic splines to model such relation. Of the 54 participants, 35 developed dementia during follow-up (including 26 cases of Alzheimer's dementia). Selenoprotein P concentrations in serum and cerebrospinal fluid were highly correlated, and in spline regression analyses they each showed a positive non-linear association with dementia risk, particularly after excluding dementia cases diagnosed within 24 months of follow-up. We also observed differences in association according to the dementia subtypes considered. Risk ratios of dementia peaked at 2-6 at the highest levels of selenoprotein P, when compared to its median level, also depending on matrix, analytical methodology and dementia subtype. Findings of this study, the first to assess selenoprotein P levels in the central nervous system in vivo and the first to use a prospective study design to evaluate associations with dementia, suggest that higher circulating concentrations of selenoprotein P, both in serum and cerebrospinal fluid, predict progression of MCI to dementia. However, further confirmation of these findings is required, given the limited statistical precision of the associations and the potential for residual confounding.

  23. Actions of Thiols, Persulfides, and Polysulfides as Free Radical Scavenging Antioxidants. International-journal

    Noriko Noguchi, Yoshiro Saito, Etsuo Niki

    Antioxidants & redox signaling 2023/05/08

    DOI: 10.1089/ars.2022.0191  

    More details Close

    SIGNIFICANCE: The essential roles of thiol compounds as redox signaling mediator and protector have been established. Recently, the roles of persulifdes and polysulfides as mediator involved in numerous physiological processes have been revealed. RECENT ADVANCES: It became possible recently to detect and measure persulfides and polysulfides in human fluids and tissues and their physiological functions including cellular signaling and protection against oxidative stress have been reported but the underlying mechanisms and dynamics remain elusive. CRITICAL ISSUES: The physiological functions of thiol compounds have been studied focusing primarily on two-electron redox reactions. In contrast, the contribution of one-electron redox mechanism, that is, free radical mediated oxidation and antioxidation have received much less attention. Considering the important effects of free radical mediated oxidation of biological molecules on pathophysiology, the antioxidant functions of thiol compounds as free radical scavenger are challenging issues. FUTURE DIRECTIONS: The antioxidant actions and dynamics of thiols, hydropersulfides and hydropolysulfides as free radical scavenging antioxidant and physiological significance remain to be established.

  24. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. International-journal

    Yusuke Hirata, Ruiqi Cai, Allen Volchuk, Benjamin E Steinberg, Yoshiro Saito, Atsushi Matsuzawa, Sergio Grinstein, Spencer A Freeman

    Current biology : CB 33 (7) 1282-1294 2023/04/10

    DOI: 10.1016/j.cub.2023.02.060  

    More details Close

    The ongoing metabolic and microbicidal pathways that support and protect cellular life generate potentially damaging reactive oxygen species (ROS). To counteract damage, cells express peroxidases, which are antioxidant enzymes that catalyze the reduction of oxidized biomolecules. Glutathione peroxidase 4 (GPX4) is the major hydroperoxidase specifically responsible for reducing lipid peroxides; this homeostatic mechanism is essential, and its inhibition causes a unique type of lytic cell death, ferroptosis. The mechanism(s) that lead to cell lysis in ferroptosis, however, are unclear. We report that the lipid peroxides formed during ferroptosis accumulate preferentially at the plasma membrane. Oxidation of surface membrane lipids increased tension on the plasma membrane and led to the activation of Piezo1 and TRP channels. Oxidized membranes thus became permeable to cations, ultimately leading to the gain of cellular Na+ and Ca2+ concomitant with loss of K+. These effects were reduced by deletion of Piezo1 and completely inhibited by blocking cation channel conductance with ruthenium red or 2-aminoethoxydiphenyl borate (2-APB). We also found that the oxidation of lipids depressed the activity of the Na+/K+-ATPase, exacerbating the dissipation of monovalent cation gradients. Preventing the changes in cation content attenuated ferroptosis. Altogether, our study establishes that increased membrane permeability to cations is a critical step in the execution of ferroptosis and identifies Piezo1, TRP channels, and the Na+/K+-ATPase as targets/effectors of this type of cell death.

  25. Antioxidant action of persulfides and polysulfides against free radical-mediated lipid peroxidation

    Takayuki Kaneko, Yuichiro Mita, Kanako Nozawa-Kumada, Masana Yazaki, Mieko Arisawa, Etsuo Niki, Noriko Noguchi, Yoshiro Saito

    Free Radical Research 56 (9-10) 1-14 2023/01/11

    Publisher: Informa UK Limited

    DOI: 10.1080/10715762.2023.2165918  

    ISSN: 1071-5762

    eISSN: 1029-2470

  26. 必須微量元素セレン研究の最前線—ダイナミクスと生理/病理的意義,重金属毒性に対する作用

    有澤 琴子, 外山 喬士, 斎藤 芳郎

    ファルマシア 59 (3) 179-184 2023

    Publisher: 公益社団法人 日本薬学会

    DOI: 10.14894/faruawpsj.59.3_179  

    ISSN: 0014-8601

    eISSN: 2189-7026

    More details Close

    必須微量元素セレンは、肝臓で合成・分泌される血漿セレン含有タンパク質 セレノプロテインP (SeP) を介して全身に輸送される。SePは受容体を介したセレン輸送に加え、重金属に対する生体防御作用を担う。一方、SePの発現異常が糖尿病発症にも関与することが明らかとなってきた。我々はSePを軸として,セレンダイナミクスの理解とその生理的・病理的意義、および重金属毒性に関する衛生薬学的意義の解明に取り組んでいる。本項では、SePの構造と機能に関して解説するとともに、我々の最近の取り組みについて紹介する。

  27. Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis.

    Yumie Takeshita, Takeo Tanaka, Hiroaki Takayama, Yuki Kita, Hisanori Goto, Yujiro Nakano, Yoshiro Saito, Toshinari Takamura

    Journal of diabetes investigation 14 (2) 230-235 2022/12/07

    DOI: 10.1111/jdi.13949  

    More details Close

    AIMS/INTRODUCTION: Selenoprotein P (SeP; encoded by SEPP1 in humans) is a hepatokine that causes impaired insulin secretion and insulin resistance. Metformin downregulates SELENOP promoter activity through an adenosine monophosphate-activated kinase-forkhead box protein O3a pathway in hepatocytes. This study aimed to test our hypothesis that circulating SeP levels are associated with the glucose-lowering effect of metformin in humans. MATERIALS AND METHODS: A total of 84 participants with poorly controlled type 2 diabetes were randomly assigned to receive metformin (1,000 mg, twice daily) or a dipeptidyl peptidase-4 inhibitor, alogliptin (25 mg, once daily) for 12 weeks. We tested metformin and alogliptin on SeP levels and factors associated therewith as a post-hoc analysis. RESULTS: Both metformin and aloglipitin did not change the SeP levels. Although metformin significantly increased the insulin secretory index secretory units of islets in transplantation only in participants with higher baseline SeP (>3.87), both agents similarly reduced fasting plasma glucose and glycated hemoglobin. SeP levels at baseline were correlated negatively with changes in SeP (r = -0.484, P = 0.004) and fasting plasma glucose (r = -0.433, P = 0.011), and positively with changes in C-peptide immunoreactivity (r = 0.420, P = 0.017) and secretory units of islets in transplantation (r = 0.388, P = 0.028) in the metformin, but not alogliptin, group. CONCLUSIONS: Higher baseline levels of SeP significantly predicted metformin-mediated, but not alogliptin-mediated, glucose-lowering and insulinotropic effects. Serum SeP levels might be a novel biomarker for predicting the outcomes of metformin therapy, which might be helpful in tailoring diabetes medication.

  28. Metal-binding properties of selenoprotein P—its relation to structure and function Peer-reviewed

    Takashi Toyama, Takayuki Kaneko, Kotoko Arisawa, Yoshiro Saito

    Metallomics Research 2 (3) 18-27 2022/12

    DOI: 10.11299/metallomicsresearch.MR202209  

  29. Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia International-journal

    Teresa Urbano, Marco Vinceti, JESSICA MANDRIOLI, Annalisa Chiari, Tommaso Filippini, Roberta Bedin, Manuela Tondelli, Cecilia Simonini, Giovanna Zamboni, Misaki Shimizu, Yoshiro Saito

    International Journal of Molecular Sciences 23 (17) 2022/08

    DOI: 10.3390/ijms23179865  

    More details Close

    Selenoprotein P, a selenium-transporter protein, has been hypothesized to play a role in the etiology of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's dementia (AD). However, data in humans are scarce and largely confined to autoptic samples. In this case-control study, we determined selenoprotein P concentrations in both the cerebrospinal fluid (CSF) and the serum of 50 individuals diagnosed with ALS, 30 with AD, 54 with mild cognitive impairment (MCI) and of 30 controls, using sandwich enzyme-linked immunosorbent assay (ELISA) methods. We found a positive and generally linear association between CSF and serum selenoprotein P concentrations in all groups. CSF selenoprotein P and biomarkers of neurodegeneration were positively associated in AD, while for MCI, we found an inverted-U-shaped relation. CSF selenoprotein P concentrations were higher in AD and MCI than in ALS and controls, while in serum, the highest concentrations were found in MCI and ALS. Logistic and cubic spline regression analyses showed an inverse association between CSF selenoprotein P levels and ALS risk, and a positive association for AD risk, while an inverted-U-shaped relation with MCI risk emerged. Conversely, serum selenoprotein P concentrations were positively associated with risk of all conditions but only in their lower range. Overall, these findings indicate some abnormalities of selenoprotein P concentrations in both the central nervous system and blood associated with ALS and neurocognitive disorders, though in different directions. These alterations may reflect either phenomena of etiologic relevance or disease-induced alterations of nutritional and metabolic status.

  30. Safety of selenium exposure and limitations of selenoprotein maximization: Molecular and epidemiologic perspectives International-journal

    Marco Vinceti, Tommaso Filippini, Ewa Jablonska, Yoshiro Saito, Lauren A. Wise

    Environmental Research 211 113092-113092 2022/08

    Publisher: Elsevier {BV}

    DOI: 10.1016/j.envres.2022.113092  

    More details Close

    Recent evidence from laboratory and epidemiologic studies has shed a different light on selenium health effects and its recommended range of environmental exposure, compared with earlier research. Specifically, epidemiologic studies in Western populations have shown adverse effects of selenium exposure at low levels, sometimes below or slightly above selenium intakes needed to maximize selenoprotein expression and activity. In addition, three recent lines of evidence in molecular and biochemical studies suggest some potential drawbacks associated with selenoprotein maximization: 1) the possibility that selenoprotein upregulation is a compensatory response to oxidative challenge, induced by selenium itself or other oxidants; 2) the capacity of selenoproteins to trigger tumor growth in some circumstances; and 3) the deleterious metabolic effects of selenoproteins and particularly of selenoprotein P. The last observation provides a toxicological basis to explain why in humans selenium intake levels as low as 60 μg/day, still in the range of selenium exposure upregulating selenoprotein expression, might start to increase risk of type 2 diabetes. Overall, these new pieces of evidence from the literature call into question the purported benefit of selenoprotein maximization, and indicate the need to reassess selenium dietary reference values and upper intake level. This reassessment should clarify which range of selenoprotein upregulation follows restoration of adequate selenium availability and which range is driven by a compensatory response to selenium toxicity and oxidative stress.

  31. Redox-sensitive DJ-1 protein: an insight into physiological roles, secretion, and therapeutic target

    Biplab Kumar Dash, Yasuomi Urano, Yoshiro Saito, Noriko Noguchi

    Redox Experimental Medicine 2022/07/01

    DOI: 10.1530/REM-22-0007  

  32. Essential trace element selenium and redox regulation: its metabolism, physiological function, and related diseases

    Yoshiro Saito

    Redox Experimental Medicine 2022/07/01

    DOI: 10.1530/REM-22-0010  

  33. Nephronectin influences EAE development by regulating the Th17/Treg balance via reactive oxygen species. International-journal

    Machiko Honda, Tatsuya Segawa, Kiyoshi Ishikawa, Masahiro Maeda, Yoshiro Saito, Shigeyuki Kon

    American journal of physiology. Cell physiology 322 (4) C699-C711-C711 2022/04/01

    Publisher: American Physiological Society

    DOI: 10.1152/ajpcell.00376.2021  

    More details Close

    Blood levels of the extracellular matrix protein nephronectin (Npnt), a protein critical for kidney development, are elevated in autoimmune experimental autoimmune encephalitis (EAE) mice, which are a model for multiple sclerosis. We found here that treatment with anti-Npnt antibody directed against the α8β1 integrin-binding site (Npnt-blocking antibody) inhibits EAE development. The selenium transporter selenoprotein P (SeP) was identified as a novel Npnt-binding partner. In EAE, Npnt induced SeP and glutathione peroxidase 1 (GPx1) expression, followed by reactive oxygen species (ROS) inhibition in CD4+ T cells; these changes were disturbed by Npnt-blocking antibody treatment, which also caused suppressed differentiation of interleukin (IL)-17-producing CD4+ T-helper cells (Th17s) and elevated differentiation of regulatory T cells (Tregs). Treatment of EAE mice with the ROS scavenger N-acetyl cysteine (NAC) blocked the Npnt-blocking antibody-induced decrease in Th17 differentiation and increase in Treg differentiation. In conclusion, the interaction between Npnt and SeP contributes to EAE development by regulating the Th17/Treg balance via the ROS level.

  34. Role of selenoprotein P expression in the function of pancreatic β cells: Prevention of ferroptosis-like cell death and stress-induced nascent granule degradation International-journal

    Nanako Kitabayashi, Shohei Nakao, Yuichiro Mita, Kotoko Arisawa, Takayuki Hoshi, Takashi Toyama, Kiyo-aki Ishii, Toshinari Takamura, Noriko Noguchi, Yoshiro Saito

    Free Radical Biology and Medicine 183 89-103 2022/04

    Publisher: Elsevier BV

    DOI: 10.1016/j.freeradbiomed.2022.03.009  

    ISSN: 0891-5849

    More details Close

    Selenoprotein P (SELENOP) is a major selenium (Se)-containing protein (selenoprotein) in human plasma that is mainly synthesized in the liver. SELENOP transports Se to the cells, while SELENOP synthesized in peripheral tissues is incorporated in a paracrine/autocrine manner to maintain the levels of cellular selenoproteins, called the SELENOP cycle. Pancreatic β cells, responsible for the synthesis and secretion of insulin, are known to express SELENOP. Here, using MIN6 cells as a mouse model for pancreatic β cells and Selenop small interfering (si)RNA, we found that Selenop gene knockdown (KD) resulted in decreased cell viability, cellular pro/insulin levels, insulin secretion, and levels of several cellular selenoproteins, including glutathione peroxidase 4 (Gpx4) and selenoprotein K (Selenok). These dysfunctions induced by Selenop siRNA were recovered by the addition of Se. Ferroptosis-like cell death, regulated by Gpx4, was involved in the decrease of cell viability by Selenop KD, while stress-induced nascent granule degradation (SINGD), regulated by Selenok, was responsible for the decrease in proinsulin. SINGD was also observed in the pancreatic β cells of Selenop knockout mice. These findings indicate a significant role of SELENOP expression for the function of pancreatic β cells by maintaining the levels of cellular selenoproteins such as GPX4 and SELENOK.

  35. Selenoprotein P-mediated reductive stress impairs cold-induced thermogenesis in brown fat. International-journal

    Swe Mar Oo, Hein Ko Oo, Hiroaki Takayama, Kiyo-Aki Ishii, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Susumu Kohno, Chiaki Takahashi, Hiroyuki Nakamura, Yoshiro Saito, Mami Matsushita, Yuko Okamatsu-Ogura, Masayuki Saito, Toshinari Takamura

    Cell reports 38 (13) 110566-110566 2022/03/29

    DOI: 10.1016/j.celrep.2022.110566  

    More details Close

    Reactive oxygen species (ROS) activate uncoupler protein 1 (UCP1) in brown adipose tissue (BAT) under physiological cold exposure and noradrenaline (NA) stimulation to increase thermogenesis. However, the endogenous regulator of ROS in activated BAT and its role in pathological conditions remain unclear. We show that serum levels of selenoprotein P (SeP; encoded by SELENOP) negatively correlate with BAT activity in humans. Physiological cold exposure downregulates Selenop in BAT. Selenop knockout mice show higher rectal temperatures and UCP1 sulfenylation during cold exposure. SeP treatment to brown adipocytes eliminated the NA-induced mitochondrial ROS by upregulating glutathione peroxidase 4 and impaired cellular thermogenesis. A high-fat/high-sucrose diet elevates serum SeP levels and diminishes the elevated NA-induced thermogenesis in BAT-Selenop KO mice. Therefore, SeP is the intrinsic factor inducing reductive stress that impairs thermogenesis in BAT and may be a potential therapeutic target for obesity and diabetes.

  36. A non-nucleotide agonist that binds covalently to cysteine residues of STING Peer-reviewed

    Kentaro Matsumoto, Shenwei Ni, Hiroyuki Arai, Takashi Toyama, Yoshiro Saito, Takehiro Suzuki, Naoshi Dohmae, Kojiro Mukai, Tomohiko Taguchi

    Cell Structure and Function 48 (1) 59-70 2022

    Publisher: Japan Society for Cell Biology

    DOI: 10.1247/csf.22085  

    ISSN: 0386-7196

    eISSN: 1347-3700

  37. Effects of the Interplay between Selenocystine and Methylmercury on Their Cytotoxicity and Glucose-Driven Insulin Secretion from Mouse Insulinoma Cells

    Daichi Chida, Takashi Toyama, Takanori Chiba, Takayuki Kaneko, Kotoko Arisawa, Yoshiro Saito

    BPB Reports 5 (4) 74-79 2022

    Publisher: Pharmaceutical Society of Japan

    DOI: 10.1248/bpbreports.5.4_74  

    eISSN: 2434-432X

  38. Methylmercury induces neuronal cell death by inducing TNF-α expression through the ASK1/p38 signaling pathway in microglia

    Takashi Toyama, Takayuki Hoshi, Takuya Noguchi, Yoshiro Saito, Atsushi Matsuzawa, Akira Naganuma, Gi-Wook Hwang

    Scientific Reports 11 (1) 2021/12

    DOI: 10.1038/s41598-021-89210-7  

    eISSN: 2045-2322

  39. Diverse cytoprotective actions of vitamin E isoforms- role as peroxyl radical scavengers and complementary functions with selenoproteins. International-journal

    Yoshiro Saito

    Free radical biology & medicine 175 121-129 2021/11/01

    Publisher: Elsevier {BV}

    DOI: 10.1016/j.freeradbiomed.2021.08.234  

    More details Close

    Vitamin E, a generic term for tocopherol (T) and tocotrienol (T3), is one of the most potent lipid-soluble antioxidants in the body. It is classified into T and T3 based on the difference in the side chain structure. T and T3 have four isoforms: α-, β-, γ-, and δ, which have different chroman rings. Both T and T3 exhibit a similar ability to scavenge free radicals, and the extent of this ability depends on the difference in the chroman structure. However, they display unique cytoprotective activities in cultured cells depending on the difference in the side chain structure. The cytoprotective effects of vitamin E have received much attention in the prevention of ferroptosis, which is a distinct form of cell death involving iron-dependent lipid peroxidation. This review focuses on the cytoprotective actions of vitamin E isoforms against oxidative stress, particularly the difference between T and T3 and its relation to cellular uptake and distribution. Moreover, the molecular mechanism for cytoprotection of vitamin E oxidation products is explained, and the complementary role of vitamin E and selenoproteins to prevent lipid peroxidation and ferroptosis is described. Furthermore, the evaluation of vitamin E's radical scavenging activity in vivo using oxidative stress markers is discussed, particularly based on kinetic data and the physiological molar ratio of vitamin E to substrates, and the limited role of vitamin E as a peroxyl radical scavenger is described. The future directions and unresolved issues related to vitamin E and lipid peroxidation are also discussed.

  40. Identification of a novel endogenous long non-coding RNA that inhibits selenoprotein P translation

    Yuichiro Mita, Risa Uchida, Sayuri Yasuhara, Kohei Kishi, Takayuki Hoshi, Yoshitaka Matsuo, Tadashi Yokooji, Yoshino Shirakawa, Takashi Toyama, Yasuomi Urano, Toshifumi Inada, Noriko Noguchi, Yoshiro Saito

    Nucleic Acids Research 2021/06/18

    Publisher: Oxford University Press (OUP)

    DOI: 10.1093/nar/gkab498  

    ISSN: 0305-1048

    eISSN: 1362-4962

    More details Close

    <title>Abstract</title> Selenoprotein P (SELENOP) is a major plasma selenoprotein that contains 10 Sec residues, which is encoded by the UGA stop codon. The mRNA for SELENOP has the unique property of containing two Sec insertion sequence (SECIS) elements, which is located in the 3′ untranslated region (3′UTR). Here, we coincidentally identified a novel gene, CCDC152, by sequence analysis. This gene was located in the antisense region of the SELENOP gene, including the 3′UTR region in the genome. We demonstrated that this novel gene functioned as a long non-coding RNA (lncRNA) that decreased SELENOP protein levels via translational rather than transcriptional, regulation. We found that the CCDC152 RNA interacted specifically and directly with the SELENOP mRNA and inhibited its binding to the SECIS-binding protein 2, resulting in the decrease of ribosome binding. We termed this novel gene product lncRNA inhibitor of SELENOP translation (L-IST). Finally, we found that epigallocatechin gallate upregulated L-IST in vitro and in vivo, to suppress SELENOP protein levels. Here, we provide a new regulatory mechanism of SELENOP translation by an endogenous long antisense ncRNA.

  41. Lipid peroxidation products as a mediator of toxicity and adaptive response - The regulatory role of selenoprotein and vitamin E. International-journal

    Yoshiro Saito

    Archives of biochemistry and biophysics 703 108840-108840 2021/05/30

    DOI: 10.1016/j.abb.2021.108840  

    More details Close

    Lipid peroxidation and its products have been investigated extensively and their biological importance, particularly in relation to physiological and pathophysiological conditions, has received considerable attention. Lipids are oxidized by three distinct mechanisms, i.e., enzymatic oxidation, nonenzymatic, free radical-mediated oxidation, and nonenzymatic, nonradical-mediated oxidation, which respectively yield specific products. Lipid hydroperoxides are the major primary products formed and are reduced to the corresponding hydroxides by antioxidative enzymes such as selenoproteins, and/or undergo secondary oxidation, generating various products with electrophilic properties, such as 4-hydroxy-2-nonenal. Lipid peroxidation induces a loss of fine structure and natural function of lipids, and can produce cytotoxicity and/or novel biological activity. This review broadly discusses the mechanisms of lipid peroxidation and its products, its utility as a biomarker for oxidative stress, the biological effects of lipid peroxidation products, including their action as a mediator of the adaptive response, and the role of the antioxidant system, particularly selenoproteins and vitamin E, in preventing lipid peroxidation and ferroptosis.

  42. Identification of an endogenous long non-coding RNA that inhibits selenoprotein P translation- New regulatory mechanism of SeP translation

    Yoshiro Saito

    Free Radical Biology and Medicine 2021

    DOI: 10.1016/J.FREERADBIOMED.2020.12.293  

  43. Selenium Transport Mechanism via Selenoprotein P-Its Physiological Role and Related Diseases. International-journal

    Yoshiro Saito

    Frontiers in nutrition 8 685517-685517 2021

    DOI: 10.3389/fnut.2021.685517  

  44. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses. International-journal

    Masato Kosuge, Emi Furusawa-Nishii, Koyu Ito, Yoshiro Saito, Kouetsu Ogasawara

    Scientific reports 10 (1) 17766-17766 2020/10/20

    DOI: 10.1038/s41598-020-74843-x  

    More details Close

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces severe pneumonia and is the cause of a worldwide pandemic. Coronaviruses, including SARS-CoV-2, have RNA proofreading enzymes in their genomes, resulting in fewer gene mutations than other RNA viruses. Nevertheless, variants of SARS-CoV-2 exist and may induce different symptoms; however, the factors and the impacts of these mutations are not well understood. We found that there is a bias to the mutations occurring in SARS-CoV-2 variants, with disproportionate mutation to uracil (U). These point mutations to U are mainly derived from cytosine (C), which is consistent with the substrate specificity of host RNA editing enzymes, APOBECs. We also found the point mutations which are consistent with other RNA editing enzymes, ADARs. For the C-to-U mutations, the context of the upstream uracil and downstream guanine from mutated position was found to be most prevalent. Further, the degree of increase of U in SARS-CoV-2 variants correlates with enhanced production of cytokines, such as TNF-α and IL-6, in cell lines when compared with stimulation by the ssRNA sequence of the isolated virus in Wuhan. Therefore, RNA editing is a factor for mutation bias in SARS-CoV-2 variants, which affects host inflammatory cytokines production.

  45. Hydrogen Peroxide Causes Cell Death via Increased Transcription of HOXB13 in Human Lung Epithelial A549 Cells. International-journal

    Naoki Endo, Takashi Toyama, Akira Naganuma, Yoshiro Saito, Gi-Wook Hwang

    Toxics 8 (4) 2020/09/28

    DOI: 10.3390/toxics8040078  

    More details Close

    Although homeobox protein B13 (HOXB13) is an oncogenic transcription factor, its role in stress response has rarely been examined. We previously reported that knockdown of HOXB13 reduces the cytotoxicity caused by various oxidative stress inducers. Here, we studied the role of HOXB13 in cytotoxicity caused by hydrogen peroxide in human lung epithelial A549 cells. The knockdown of HOXB13 reduced hydrogen peroxide-induced cytotoxicity; however, this phenomenon was largely absent in the presence of antioxidants (Trolox or N-acetyl cysteine (NAC)). This suggests that HOXB13 may be involved in the cytotoxicity caused by hydrogen peroxide via the production of reactive oxygen species (ROS). Hydrogen peroxide also increased both the mRNA and protein levels of HOXB13. However, these increases were rarely observed in the presence of a transcriptional inhibitor, which suggests that hydrogen peroxide increases protein levels via increased transcription of HOXB13. Furthermore, cell death occurred in A549 cells that highly expressed HOXB13. However, this cell death was mostly inhibited by treatment with antioxidants. Taken together, our findings indicate that HOXB13 may be a novel factor involved in the induction of oxidative stress, which causes cell death via intracellular ROS production.

  46. The Association Between Concurrence of Infection and the Onset of Severe Eruption or Liver Injury in Patients Using Antipyretic Analgesics: A Matched, Nested Case‐Control Study

    Takuya Imatoh, Kimie Sai, Yoshiro Saito

    The Journal of Clinical Pharmacology 2020/09

    DOI: 10.1002/jcph.1613  

  47. DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN. International-journal

    Takeshi Niki, Jinro Endo, Kazuko Takahashi-Niki, Tatsuki Yasuda, Asami Okamoto, Yoshiro Saito, Hiroyoshi Ariga, Sanae M M Iguchi-Ariga

    Brain research 1729 146641-146641 2020/02/15

    Publisher: Elsevier {BV}

    DOI: 10.1016/j.brainres.2019.146641  

    More details Close

    DJ-1 was identified as an oncogene and also as a causative gene for a familial form of Parkinson disease (PD). DJ-1 plays various roles in anti-oxidative stress response. Superfluous oxidation of DJ-1 at cysteine residue 106 (C106), an inactive form of DJ-1, was observed in PD patients. DJ-1-binding compound B, which specifically bound to the C106 region of DJ-1, has been isolated and it has been shown to prevent oxidative stress-induced cell death through maintaining active forms of DJ-1 by inhibiting its superfluous oxidation. The molecular mechanism of the action of compound B, however, has not been fully elucidated. In this study, we found that compound B stimulated transcriptional activity of Nrf2 in H2O2-treated SH-SY5Y cells by inhibiting its degradation through the ubiquitin-proteasome system. Although Keap 1 is a major negative regulator of Nrf2, compound B strongly increased Nrf2 activity in Keap1-mutant A549 cells but not in PTEN-null PC3 and PTEN-knockout SH-SY5Y cells. Furthermore, treatment of cells with inhibitors of the PI3-kinase/Akt pathway inhibited the effect of compound B, and compound B increased the binding of PTEN to DJ-1 and decreased lipid phosphatase activity of PTEN concomitantly with increased oxidation of PTEN, an inactive form of PTEN. These results suggest that compound B enhances transcriptional activity of Nrf2 under an oxidative stress condition in a Keap1-independent manner and that its activity is elicited by activation of the PI3Kinase/Akt pathway with DJ-1-dependent inactivation of PTEN, leading to protection of oxidative stress-induced cell death.

  48. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess.

    Yoshiro Saito

    Journal of clinical biochemistry and nutrition 66 (1) 1-7 2020/01

    DOI: 10.3164/jcbn.19-31  

  49. Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More.

    Ryouhei Tsutsumi, Yoshiro Saito

    Biological & pharmaceutical bulletin 43 (3) 366-374 2020

    DOI: 10.1248/bpb.b19-00837  

  50. Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension. International-journal Peer-reviewed

    Nobuhiro Kikuchi, Kimio Satoh, Taijyu Satoh, Nobuhiro Yaoita, Mohammad Abdul Hai Siddique, Junichi Omura, Ryo Kurosawa, Masamichi Nogi, Shinichiro Sunamura, Satoshi Miyata, Hirofumi Misu, Yoshiro Saito, Hiroaki Shimokawa

    Arteriosclerosis, thrombosis, and vascular biology 39 (12) 2553-2562 2019/12

    DOI: 10.1161/ATVBAHA.119.313267  

    ISSN: 1079-5642

  51. Selenoprotein P as a significant regulator of pancreatic β cell function Peer-reviewed

    Yoshiro Saito

    The Journal of Biochemistry 2019/08/22

    Publisher: Oxford University Press ({OUP})

    DOI: 10.1093/jb/mvz061  

    ISSN: 0021-924X

  52. Polymerization of Oxidized DJ-1 via Noncovalent and Covalent Binding: Significance of Disulfide Bond Formation Peer-reviewed

    Mayuka Kobayashi, Kana Muramatsu, Takamitsu Haruyama, Haruka Uesugi, Ai Kikuchi, Hiroki Konno, Noriko Noguchi, Yoshiro Saito

    ACS Omega 4 (6) 9603-9614 2019/06/30

    Publisher: American Chemical Society ({ACS})

    DOI: 10.1021/acsomega.9b00324  

  53. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans. Peer-reviewed

    Mohri K, Misu H, Takayama H, Ishii KA, Kikuchi A, Lan F, Enyama Y, Takeshita Y, Saito Y, Kaneko S, Takamura T

    Biological & pharmaceutical bulletin 42 (3) 373-378 2019/03

    DOI: 10.1248/bpb.b18-00549  

    ISSN: 0918-6158

    More details Close

    A hepatokine is a collective term for liver-derived secretory factors whose previously-unrecognized functions have been recently elucidated. We have rediscovered selenoprotein P (SeP) and leukocyte cell-derived chemotaxin 2 (LECT2) as hepatokines that are involved in the development of insulin resistance and hyperglycemia. The aim of this study was to determine whether and, if so, how oral glucose loading alters the two hepatokines in humans. We measured concentrations of serum SeP and plasma LECT2 during 75 g oral glucose tolerance test (OGTT) (n = 20) in people with various degrees of glucose tolerance. In OGTT, concentrations of both serum SeP and plasma LECT2 decreased at 120 min compared with the baseline values, irrespective of the severity of glucose intolerance. Decrement of serum SeP during OGTT showed no correlations to the clinical parameters associated with insulin resistance or insulin secretion. In multiple stepwise regression analyses, plasma cortisol was selected as the variable to explain the changes in plasma concentrations of LECT2. The current data reveal the acute inhibitory actions of oral intake of glucose on circulating SeP and LECT2 in humans, irrespective of the severity of glucose intolerance. This study suggests that circulating SeP is regulated by the unknown clinical factors other than insulin and glucose during OGTT.

  54. Diagnostic and prognostic significance of serum levels of selenoprotein P in patients with pulmonary arterial hypertension

    Yoshiro Saito

    European Heart Journal 2019

  55. Chemical Reactivity and Cellular Uptake of Tocopherols and Tocotrienols

    Yoshiro Saito

    Food Biosensors 2019

  56. セレノプロテインPを用いた肺動脈性肺高血圧症の診断と予後評価法の開発 Peer-reviewed

    菊地 順裕, 佐藤 公雄, 大村 淳一, 佐藤 大樹, 黒澤 亮, 野木 正道, 砂村 慎一郎, 矢尾板 信裕, 宮田 敏, 御簾 博文, 斎藤 芳郎, 下川 宏明

    血管 42 (1) 54-54 2019/01

    Publisher: 日本心脈管作動物質学会

    ISSN: 0911-4637

  57. Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target". International-journal Peer-reviewed

    Kikuchi N, Satoh K, Saito Y, Shimokawa H

    Circulation 139 (5) 724-725 2019/01

    DOI: 10.1161/CIRCULATIONAHA.118.038479  

    ISSN: 0009-7322

  58. Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population Peer-reviewed

    Swe Mar Oo, Hirofumi Misu, Yoshiro Saito, Mutsumi Tanaka, Seiji Kato, Yuki Kita, Hiroaki Takayama, Yumie Takeshita, Takehiro Kanamori, Toru Nagano, Masatoshi Nakagen, Takeshi Urabe, Naoto Matsuyama, Shuichi Kaneko, Toshinari Takamura

    Scientific Reports 8 (1) 16727 2018/12

    Publisher: Springer Science and Business Media {LLC}

    DOI: 10.1038/s41598-018-35067-2  

    eISSN: 2045-2322

  59. Distribution of oxidized DJ-1 in Parkinson’s disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin Peer-reviewed

    Mita, Y., Kataoka, Y., Saito, Y., Kashi, T., Hayashi, K., Iwasaki, A., Imanishi, T., Miyasaka, T., Noguchi, N.

    Scientific Reports 8 (1) 12056 2018/08/13

    Publisher: Springer Nature

    DOI: 10.1038/s41598-018-30561-z  

  60. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. International-journal Peer-reviewed

    Nobuhiro Kikuchi, Kimio Satoh, Ryo Kurosawa, Nobuhiro Yaoita, Md Elias-Al-Mamun, Mohammad Abdul Hai Siddique, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Satoshi Miyata, Yoshiro Saito, Yasushi Hoshikawa, Yoshinori Okada, Hiroaki Shimokawa

    Circulation 138 (6) 600-623 2018/08/07

    DOI: 10.1161/CIRCULATIONAHA.117.033113  

    ISSN: 0009-7322

    More details Close

    BACKGROUND: Excessive proliferation and apoptosis resistance of pulmonary artery smooth muscle cells (PASMCs) are key mechanisms of pulmonary arterial hypertension (PAH). Despite the multiple combination therapy, a considerable number of patients develop severe pulmonary hypertension (PH) because of the lack of diagnostic biomarker and antiproliferative therapies for PASMCs. METHODS: Microarray analyses were used to identify a novel therapeutic target for PAH. In vitro experiments, including lung and serum samples from patients with PAH, cultured PAH-PASMCs, and high-throughput screening of 3336 low-molecular-weight compounds, were used for mechanistic study and exploring a novel therapeutic agent. Five genetically modified mouse strains, including PASMC-specific selenoprotein P (SeP) knockout mice and PH model rats, were used to study the role of SeP and therapeutic capacity of the compounds for the development of PH in vivo. RESULTS: Microarray analysis revealed a 32-fold increase in SeP in PAH-PASMCs compared with control PASMCs. SeP is a widely expressed extracellular protein maintaining cellular metabolism. Immunoreactivity of SeP was enhanced in the thickened media of pulmonary arteries in PAH. Serum SeP levels were also elevated in patients with PH compared with controls, and high serum SeP predicted poor outcome. SeP-knockout mice ( SeP-/-) exposed to chronic hypoxia showed significantly reduced right ventricular systolic pressure, right ventricular hypertrophy, and pulmonary artery remodeling compared with controls. In contrast, systemic SeP-overexpressing mice showed exacerbation of hypoxia-induced PH. Furthermore, PASMC-specific SeP-/- mice showed reduced hypoxia-induced PH compared with controls, whereas neither liver-specific SeP knockout nor liver-specific SeP-overexpressing mice showed significant differences with controls. Altogether, protein levels of SeP in the lungs were associated with the development of PH. Mechanistic experiments demonstrated that SeP promotes PASMC proliferation and resistance to apoptosis through increased oxidative stress and mitochondrial dysfunction, which were associated with activated hypoxia-inducible factor-1α and dysregulated glutathione metabolism. It is important to note that the high-throughput screening of 3336 compounds identified that sanguinarine, a plant alkaloid with antiproliferative effects, reduced SeP expression and proliferation in PASMCs and ameliorated PH in mice and rats. CONCLUSIONS: These results indicate that SeP promotes the development of PH, suggesting that it is a novel biomarker and therapeutic target of the disorder.

  61. Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein. International-journal Peer-reviewed

    Yuko Yamagishi, Kazumasa Saigoh, Yoshiro Saito, Ikuko Ogawa, Yoshiyuki Mitsui, Yukihiro Hamada, Makoto Samukawa, Hidekazu Suzuki, Motoi Kuwahara, Makito Hirano, Noriko Noguchi, Susumu Kusunoki

    Neuroscience research 128 58-62 2018/03

    DOI: 10.1016/j.neures.2017.06.008  

    ISSN: 0168-0102

  62. Pleckstrin homology domain of p210 BCR-ABL interacts with cardiolipin to regulate its mitochondrial translocation and subsequent mitophagy Peer-reviewed

    Shimasaki, K., Watanabe-Takahashi, M., Umeda, M., Funamoto, S., Saito, Y., Noguchi, N., Kumagai, K., Hanada, K., Tsukahara, F., Maru, Y., Shibata, N., Naito, M., Nishikawa, K.

    Genes to Cells 23 (1) 22-34 2018

    Publisher: Wiley

    DOI: 10.1111/gtc.12544  

    ISSN: 1356-9597

  63. PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5 Peer-reviewed

    Lee, D.-H., Kim, D., Kim, S.T., Jeong, S., Kim, J.L., Shim, S.M., Heo, A.J., Song, X., Guo, Z.S., Bartlett, D.L., Oh, S.C., Lee, J., Saito, Y., Kim, B.Y., Kwon, Y.T., Lee, Y.J.

    Autophagy 14 (11) 1870-1885 2018

    DOI: 10.1080/15548627.2018.1491212  

    ISSN: 1554-8627

  64. Hydrogen peroxide-reducing factor released by PC12D cells increases cell tolerance against oxidative stress Peer-reviewed

    Muraishi, A., Haneta, E., Saito, Y., Hitomi, Y., Sano, M., Noguchi, N.

    Biological and Pharmaceutical Bulletin 41 (5) 777-785 2018

    DOI: 10.1248/bpb.b18-00016  

    ISSN: 0918-6158

    eISSN: 1347-5215

  65. Comparison of human selenoprotein P determinants in serum between our original methods and commercially available kits Peer-reviewed

    Saito, Y., Misu, H., Takayama, H., Takashima, S.-I., Usui, S., Takamura, M., Kaneko, S., Takamura, T., Noguchi, N.

    Biological and Pharmaceutical Bulletin 41 (5) 828-832 2018

    Publisher: Pharmaceutical Society of Japan

    DOI: 10.1248/bpb.b18-00046  

    ISSN: 0918-6158

    eISSN: 1347-5215

  66. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway Peer-reviewed

    Urano, Y., Mori, C., Fuji, A., Konno, K., Yamamoto, T., Yashirogi, S., Ando, M., Saito, Y., Noguchi, N.

    Autophagy 14 (11) 1943-1958 2018

    DOI: 10.1080/15548627.2018.1493043  

    ISSN: 1554-8627

  67. Tocopherol suppresses 24(S)-hydroxycholesterol-induced cell death via inhibition of CaMKII phosphorylation International-journal Peer-reviewed

    Kimura, Y., Asa, M., Urano, Y., Saito, Y., Nishikawa, K., Noguchi, N.

    Biochimie 153 203-209 2018

    Publisher: Elsevier {BV}

    DOI: 10.1016/j.biochi.2018.07.004  

    ISSN: 0300-9084

  68. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models Peer-reviewed

    Yuichiro Mita, Kaho Nakayama, Shogo Inari, Yukina Nishito, Yuya Yoshioka, Naoko Sakai, Kanade Sotani, Takahiro Nagamura, Yuki Kuzuhara, Kumi Inagaki, Miki Iwasaki, Hirofumi Misu, Masaya Ikegawa, Toshinari Takamura, Noriko Noguchi, Yoshiro Saito

    NATURE COMMUNICATIONS 8 (1) 2017/11

    DOI: 10.1038/s41467-017-01863-z  

    ISSN: 2041-1723

  69. Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes

    Natsumi Tajima-Shirasaki, Kiyo-aki Ishil, Hiroaki Takayama, Takayoshi Shirasaki, Hisakazu Iwama, Keita Chikamoto, Yoshiro Saito, Yasumasa Iwasaki, Atsushi Teraguchi, Fei Lan, Akihiro Kikuchi, Yumie Takeshita, Koji Murao, Seiichi Matsugo, Shuichi Kaneko, Hirofumi Misu, Toshinari Takamura

    JOURNAL OF BIOLOGICAL CHEMISTRY 292 (26) 10791-10800 2017/06

    DOI: 10.1074/jbc.M116.747006  

    ISSN: 0021-9258

    eISSN: 1083-351X

  70. Effect of vitamin E on 24(S)-hydroxycholesterol-induced necroptosis-like cell death and apoptosis

    Takaya Nakazawa, Yuta Miyanoki, Yasuomi Urano, Madoka Uehara, Yoshiro Saito, Noriko Noguchi

    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 169 69-76 2017/05

    DOI: 10.1016/j.jsbmb.2016.03.003  

    ISSN: 0960-0760

  71. Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle Peer-reviewed

    Hirofumi Misu, Hiroaki Takayama, Yoshiro Saito, Yuichiro Mita, Akihiro Kikuchi, Kiyo-aki Ishii, Keita Chikamoto, Takehiro Kanamori, Natsumi Tajima, Fei Lan, Yumie Takeshita, Masao Honda, Mutsumi Tanaka, Seiji Kato, Naoto Matsuyama, Yuya Yoshioka, Kaito Iwayama, Kumpei Tokuyama, Nobuhiko Akazawa, Seiji Maeda, Kazuhiro Takekoshi, Seiichi Matsugo, Noriko Noguchi, Shuichi Kaneko, Toshinari Takamura

    NATURE MEDICINE 23 (4) 508-+ 2017/04

    DOI: 10.1038/nm.4295  

    ISSN: 1078-8956

    eISSN: 1546-170X

  72. Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47(phox) Peer-reviewed

    Bharatwaj Sowrirajan, Yoshiro Saito, Deepak Poudyal, Qian Chen, Hongyan Sui, Suk See DeRavin, Hiromi Imamichi, Toyotaka Sato, Douglas B. Kuhns, Noriko Noguchi, Harry L. Malech, H. Clifford Lane, Tomozumi Imamichi

    SCIENTIFIC REPORTS 7 43441 2017/02

    DOI: 10.1038/srep43441  

    ISSN: 2045-2322

  73. DJ-1 as a biomarker of Parkinson’s disease Peer-reviewed

    Yoshiro Saito

    Advances in Experimental Medicine and Biology 1037 149-171 2017

    Publisher: Springer New York LLC

    DOI: 10.1007/978-981-10-6583-5_10  

    ISSN: 2214-8019 0065-2598

  74. Oxidized Lipoprotein as a Major Vessel Cell Proliferator in Oxidized Human Serum

    Yoshiro Saito, Noriko Noguchi

    PLOS ONE 11 (8) 2016/08

    DOI: 10.1371/journal.pone.0160530  

    ISSN: 1932-6203

  75. Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients

    Yoshiro Saito, Yoko Akazawa-Ogawa, Akihiro Matsumura, Kazumasa Saigoh, Sayoko Itoh, Kenta Sutou, Mayuka Kobayashi, Yuichiro Mita, Mototada Shichiri, Shin Hisahara, Yasuo Hara, Harutoshi Fujimura, Hiroyuki Takamatsu, Yoshihisa Hagihara, Yasukazu Yoshida, Takao Hamakubo, Susumu Kusunoki, Shun Shimohama, Noriko Noguchi

    SCIENTIFIC REPORTS 6 2016/07

    DOI: 10.1038/srep30793  

    ISSN: 2045-2322

  76. Development of a Sol Particle Homogeneous Immunoassay for Measuring Full-Length Selenoprotein P in Human Serum

    Mutsumi Tanaka, Yoshiro Saito, Hirofumi Misu, Seiji Kato, Yuki Kita, Yumie Takeshita, Takehiro Kanamori, Toru Nagano, Masatoshi Nakagen, Takeshi Urabe, Toshinari Takamura, Shuichi Kaneko, Kazuhiko Takahashi, Naoto Matsuyama

    JOURNAL OF CLINICAL LABORATORY ANALYSIS 30 (2) 114-122 2016/03

    DOI: 10.1002/jcla.21824  

    ISSN: 0887-8013

    eISSN: 1098-2825

  77. The protective role of DJ-1 in ultraviolet-induced damage of human skin: DJ-1 levels in the stratum corneum as an indicator of antioxidative defense

    Shioji Ishiwatari, Minako Takahashi, Chie Yasuda, Maho Nakagawa, Yoshiro Saito, Noriko Noguchi, Shoko Matsukuma

    ARCHIVES OF DERMATOLOGICAL RESEARCH 307 (10) 925-935 2015/12

    DOI: 10.1007/s00403-015-1605-8  

    ISSN: 0340-3696

    eISSN: 1432-069X

  78. Enhancement of lipid peroxidation and its amelioration by vitamin E in a subject with mutations in the SBP2 gene

    Yoshiro Saito, Mototada Shichiri, Takashi Hamajima, Noriko Ishida, Yuichiro Mita, Shohei Nakao, Yoshihisa Hagihara, Yasukazu Yoshida, Kazuhiko Takahashi, Etsuo Niki, Noriko Noguchi

    JOURNAL OF LIPID RESEARCH 56 (11) 2172-2182 2015/11

    DOI: 10.1194/jlr.M059105  

    ISSN: 0022-2275

    eISSN: 1539-7262

  79. New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death

    Noriko Noguchi, Yasuomi Urano, Wakako Takabe, Yoshiro Saito

    FREE RADICAL BIOLOGY AND MEDICINE 87 366-372 2015/10

    DOI: 10.1016/j.freeradbiomed.2015.06.036  

    ISSN: 0891-5849

    eISSN: 1873-4596

  80. 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8

    Diep-Khanh Ho Vo, Yasuomi Urano, Wakako Takabe, Yoshiro Saito, Noriko Noguchi

    STEROIDS 99 230-237 2015/07

    DOI: 10.1016/j.steroids.2015.02.007  

    ISSN: 0039-128X

    eISSN: 1878-5867

  81. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells

    Kazuhide Ishikura, Hirofumi Misu, Masafumi Kumazaki, Hiroaki Takayama, Naoto Matsuzawa-Nagata, Natsumi Tajima, Keita Chikamoto, Fei Lan, Hitoshi Ando, Tsuguhito Ota, Masaru Sakurai, Yumie Takeshita, Kenichiro Kato, Akio Fujimura, Ken-ichi Miyamoto, Yoshiro Saito, Satomi Kameo, Yasuo Okamoto, Yoh Takuwa, Kazuhiko Takahashi, Hiroyasu Kidoya, Nobuyuki Takakura, Shuichi Kaneko, Toshinari Takamura

    DIABETOLOGIA 57 (9) 1968-1976 2014/09

    DOI: 10.1007/s00125-014-3306-9  

    ISSN: 0012-186X

    eISSN: 1432-0428

  82. LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance

    Fei Lan, Hirofumi Misu, Keita Chikamoto, Hiroaki Takayama, Akihiro Kikuchi, Kensuke Mohri, Noboru Takata, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Yumie Takeshita, Hiroyo Noda, Yukako Matsumoto, Tsuguhito Ota, Toru Nagano, Masatoshi Nakagen, Ken-ichi Miyamoto, Kanako Takatsuki, Toru Seo, Kaito Iwayama, Kunpei Tokuyama, Seiichi Matsugo, Hong Tang, Yoshiro Saito, Satoshi Yamagoe, Shuichi Kaneko, Toshinari Takamura

    DIABETES 63 (5) 1649-1664 2014/05

    DOI: 10.2337/db13-0728  

    ISSN: 0012-1797

    eISSN: 1939-327X

  83. Oxidized DJ-1 as a possible biomarker of Parkinson's disease

    Yoshiro Saito

    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION 54 (3) 138-144 2014/05

    DOI: 10.3164/jcbn.13-108  

    ISSN: 0912-0009

    eISSN: 1880-5086

  84. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance. International-journal

    Fei Lan, Hirofumi Misu, Keita Chikamoto, Hiroaki Takayama, Akihiro Kikuchi, Kensuke Mohri, Noboru Takata, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Yumie Takeshita, Hiroyo Noda, Yukako Matsumoto, Tsuguhito Ota, Toru Nagano, Masatoshi Nakagen, Ken-ichi Miyamoto, Kanako Takatsuki, Toru Seo, Kaito Iwayama, Kunpei Tokuyama, Seiichi Matsugo, Hong Tang, Yoshiro Saito, Satoshi Yamagoe, Shuichi Kaneko, Toshinari Takamura

    Diabetes 63 (5) 1649-64 2014/05

    Publisher: American Diabetes Association

    DOI: 10.2337/db13-0728  

    ISSN: 1939-327x

    More details Close

    Recent articles have reported an association between fatty liver disease and systemic insulin resistance in humans, but the causal relationship remains unclear. The liver may contribute to muscle insulin resistance by releasing secretory proteins called hepatokines. Here we demonstrate that leukocyte cell-derived chemotaxin 2 (LECT2), an energy-sensing hepatokine, is a link between obesity and skeletal muscle insulin resistance. Circulating LECT2 positively correlated with the severity of both obesity and insulin resistance in humans. LECT2 expression was negatively regulated by starvation-sensing kinase adenosine monophosphate-activated protein kinase in H4IIEC hepatocytes. Genetic deletion of LECT2 in mice increased insulin sensitivity in the skeletal muscle. Treatment with recombinant LECT2 protein impaired insulin signaling via phosphorylation of Jun NH2-terminal kinase in C2C12 myocytes. These results demonstrate the involvement of LECT2 in glucose metabolism and suggest that LECT2 may be a therapeutic target for obesity-associated insulin resistance.

  85. Diverse functions of 24(S)-hydroxycholesterol in the brain

    Noriko Noguchi, Yoshiro Saito, Yasuomi Urano

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 446 (3) 692-696 2014/04

    DOI: 10.1016/j.bbrc.2014.02.010  

    ISSN: 0006-291X

    eISSN: 1090-2104

  86. 7-Hydroxycholestrol as a possible biomarker of cellular lipid peroxidation: Difference between cellular and plasma lipid peroxidation

    Yoshiro Saito, Noriko Noguchi

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 446 (3) 741-744 2014/04

    DOI: 10.1016/j.bbrc.2013.12.083  

    ISSN: 0006-291X

    eISSN: 1090-2104

  87. パーキンソン病における酸化DJ-1測定のバイオマーカーとしての意義の検討 Peer-reviewed

    小川郁子, 斎藤芳郎, 西郷和真, 細井幸恵, 三井良之, 野口範子, 楠 進

    Brain and Nerve 66 471-477 2014

  88. The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for parkinson's disease

    Ikuko Ogawa, Yoshiro Saito, Kazumasa Saigoh, Yoshie Hosoi, Yoshiyuki Mitsui, Noriko Noguchi, Susumu Kusunoki

    Brain and Nerve 66 (4) 471-477 2014

    Publisher: Igaku-Shoin Ltd

    ISSN: 1881-6096

  89. Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death

    Akishi Okabe, Yasuomi Urano, Sayoko Itoh, Naoto Suda, Rina Kotani, Yuki Nishimura, Yoshiro Saito, Noriko Noguchi

    REDOX BIOLOGY 2 28-35 2014

    DOI: 10.1016/j.redox.2013.11.007  

    ISSN: 2213-2317

  90. Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA: cholesterol acyltransferase 1

    K. Yamanaka, Y. Urano, W. Takabe, Y. Saito, N. Noguchi

    CELL DEATH & DISEASE 5 2014/01

    DOI: 10.1038/cddis.2013.524  

    ISSN: 2041-4889

  91. Immunostaining of oxidized DJ-1 in human and mouse brains

    Yoshiro Saito, Tomohiro Miyasaka, Hiroyuki Hatsuta, Kazuko Takahashi-Niki, Kojiro Hayashi, Yuichiro Mita, Osamu Kusano-Arai, Hiroko Iwanari, Hiroyoshi Ariga, Takao Hamakubo, Yasukazu Yoshida, Etsuo Niki, Shigeo Murayama, Yasuo Ihara, Noriko Noguchi

    Journal of Neuropathology and Experimental Neurology 73 (7) 714-728 2014

    Publisher: Lippincott Williams and Wilkins

    DOI: 10.1097/NEN.0000000000000087  

    ISSN: 1554-6578 0022-3069

  92. Metformin Suppresses Expression of the Selenoprotein P Gene via an AMP-activated Kinase (AMPK)/FoxO3a Pathway in H4IIEC3 Hepatocytes

    Hiroaki Takayama, Hirofumi Misu, Hisakazu Iwama, Keita Chikamoto, Yoshiro Saito, Koji Murao, Atsushi Teraguchi, Fei Lan, Akihiro Kikuchi, Reina Saito, Natsumi Tajima, Takayoshi Shirasaki, Seiichi Matsugo, Ken-ichi Miyamoto, Shuichi Kaneko, Toshinari Takamura

    JOURNAL OF BIOLOGICAL CHEMISTRY 289 (1) 335-345 2014/01

    DOI: 10.1074/jbc.M113.479386  

    ISSN: 0021-9258

    eISSN: 1083-351X

  93. The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for parkinson's disease Peer-reviewed

    Ikuko Ogawa, Yoshiro Saito, Kazumasa Saigoh, Yoshie Hosoi, Yoshiyuki Mitsui, Noriko Noguchi, Susumu Kusunoki

    Brain and Nerve 66 (4) 471-477 2014

    Publisher: Igaku-Shoin Ltd

    ISSN: 1881-6096

  94. Oxidized DJ-1 Inhibits p53 by Sequestering p53 from Promoters in a DNA-Binding Affinity-Dependent Manner

    Izumi Kato, Hiroshi Maita, Kazuko Takahashi-Niki, Yoshiro Saito, Noriko Noguchi, Sanae M. M. Iguchi-Ariga, Hiroyoshi Ariga

    MOLECULAR AND CELLULAR BIOLOGY 33 (2) 340-359 2013/01

    DOI: 10.1128/MCB.01350-12  

    ISSN: 0270-7306

  95. Serum selenium and selenoprotein P in patients with silicosis

    Basilua Andre Muzembo, Narongpon Dumavibhat, N'landu Roger Ngatu, Masamitsu Eitoku, Ryoji Hirota, Shinichi Kondo, Yoji Deguchi, Yoshiro Saito, Kazuhiko Takahashi, Narufumi Suganuma

    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY 27 (1) 40-44 2013

    DOI: 10.1016/j.jtemb.2012.05.003  

    ISSN: 0946-672X

  96. Enhanced CD36 expression changes the role of Nrf2 activation from anti-atherogenic to pro-atherogenic in apoE-deficient mice

    Hirotaka Sawada, Yoshiro Saito, Noriko Noguchi

    ATHEROSCLEROSIS 225 (1) 83-90 2012/11

    DOI: 10.1016/j.atherosclerosis.2012.08.023  

    ISSN: 0021-9150

  97. Cytoprotective effects of geraniin against peroxynitrite- and peroxyl radical-induced cell death via free radical scavenging activity

    Lai Teng Ling, Yoshiro Saito, Uma D. Palanisamy, Hwee Ming Cheng, Noriko Noguchi

    FOOD CHEMISTRY 132 (4) 1899-1907 2012/06

    DOI: 10.1016/j.foodchem.2011.12.024  

    ISSN: 0308-8146

    eISSN: 1873-7072

  98. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation (vol 166, pg 757, 2012)

    Takashi Hamajima, Yuichi Mushimoto, Hironori Kobayashi, Yoshiro Saito, Kaxumichi Onigata

    EUROPEAN JOURNAL OF ENDOCRINOLOGY 166 (5) 957-957 2012/05

    DOI: 10.1530/EJE-11-0812e  

    ISSN: 0804-4643

  99. Inverse Correlation between Serum Levels of Selenoprotein P and Adiponectin in Patients with Type 2 Diabetes

    Hirofumi Misu, Kazuhide Ishikura, Seiichiro Kurita, Yumie Takeshita, Tsuguhito Ota, Yoshiro Saito, Kazuhiko Takahashi, Shuichi Kaneko, Toshinari Takamura

    PLOS ONE 7 (4) e34952 2012/04

    DOI: 10.1371/journal.pone.0034952  

    ISSN: 1932-6203

  100. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation

    Takashi Hamajima, Yuichi Mushimoto, Hironori Kobayashi, Yoshiro Saito, Kazumichi Onigata

    EUROPEAN JOURNAL OF ENDOCRINOLOGY 166 (4) 757-764 2012/04

    DOI: 10.1530/EJE-11-0812  

    ISSN: 0804-4643

  101. Selenoprotein P

    Yoshiro Saito, Kazuhiko Takahashi

    Advanced Topics in Science and Technology in China 77-88 2012

    Publisher: Springer

    DOI: 10.1007/978-3-642-22236-8_5  

    ISSN: 1995-6827 1995-6819

  102. A novel fluorescent probe with high sensitivity and selective detection of lipid hydroperoxides in cells

    Kazunori Yamanaka, Yoshiro Saito, Junji Sakiyama, Yuya Ohuchi, Fumio Oseto, Noriko Noguchi

    RSC ADVANCES 2 (20) 7894-7900 2012

    DOI: 10.1039/c2ra20816d  

    ISSN: 2046-2069

  103. 赤血球画分を用いた酸化DJ-1定量の検討

    松村 晃寛, 久原 真, 齊藤 正樹, 川又 純, 今井 富裕, 下濱 俊, 斎藤 芳郎, 野口 範子, 二木 鋭雄

    臨床神経学 51 (12) 1266-1266 2011/12

    Publisher: (一社)日本神経学会

    ISSN: 0009-918X

    eISSN: 1882-0654

  104. Oxidation of DJ-1 Induced by 6-Hydroxydopamine Decreasing Intracellular Glutathione

    Akiko Miyama, Yoshiro Saito, Kazunori Yamanaka, Kojiro Hayashi, Takao Hamakubo, Noriko Noguchi

    PLOS ONE 6 (11) e27883 2011/11

    DOI: 10.1371/journal.pone.0027883  

    ISSN: 1932-6203

  105. 24(S)-Hydroxycholesterol Induces Neuronal Cell Death through Necroptosis, a Form of Programmed Necrosis

    Kazunori Yamanaka, Yoshiro Saito, Tohru Yamamori, Yasuomi Urano, Noriko Noguchi

    JOURNAL OF BIOLOGICAL CHEMISTRY 286 (28) 24666-24673 2011/07

    DOI: 10.1074/jbc.M111.236273  

    ISSN: 0021-9258

  106. Selenoprotein-P is Down-Regulated in Prostate Cancer, Which Results in Lack of Protection Against Oxidative Damage

    Oscar Gonzalez-Moreno, Noemi Boque, Miriam Redrado, Fermin Milagro, Javier Campion, Tobias Endermann, Kazuhiko Takahashi, Yoshiro Saito, Raul Catena, Lutz Schomburg, Alfonso Calvo

    PROSTATE 71 (8) 824-834 2011/06

    DOI: 10.1002/pros.21298  

    ISSN: 0270-4137

  107. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction

    Akira Kobayashi, Takako Tsukide, Tomohiro Miyasaka, Tomoko Morita, Tatsuya Mizoroki, Yoshiro Saito, Yasuo Ihara, Akihiko Takashima, Noriko Noguchi, Akiyoshi Fukamizu, Yosuke Hirotsu, Makiko Ohtsuji, Fumiki Katsuoka, Masayuki Yamamoto

    GENES TO CELLS 16 (6) 692-703 2011/06

    DOI: 10.1111/j.1365-2443.2011.01522.x  

    ISSN: 1356-9597

  108. Selenoprotein-P is Down-Regulated in Prostate Cancer, Which Results in Lack of Protection Against Oxidative Damage

    Oscar Gonzalez-Moreno, Noemi Boque, Miriam Redrado, Fermin Milagro, Javier Campion, Tobias Endermann, Kazuhiko Takahashi, Yoshiro Saito, Raul Catena, Lutz Schomburg, Alfonso Calvo

    PROSTATE 71 (8) 824-834 2011/06

    DOI: 10.1002/pros.21298  

    ISSN: 0270-4137

  109. alpha-Tocopheryl phosphate: Uptake, hydrolysis, and antioxidant action in cultured cells and mouse

    Keiko Nishio, Noriko Ishida, Yoshiro Saito, Yoko Ogawa-Akazawa, Mototada Shichiri, Yasukazu Yoshida, Yoshihisa Hagihara, Noriko Noguchi, John Chirico, Jeffrey Atkinson, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 50 (12) 1794-1800 2011/06

    DOI: 10.1016/j.freeradbiomed.2011.03.021  

    ISSN: 0891-5849

    eISSN: 1873-4596

  110. Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity

    Tohru Yamamori, Ayano Mizobata, Yoshiro Saito, Yasuomi Urano, Osamu Inanami, Kaikobad Irani, Noriko Noguchi

    FREE RADICAL RESEARCH 45 (3) 342-350 2011/03

    DOI: 10.3109/10715762.2010.532496  

    ISSN: 1071-5762

  111. Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity

    Tohru Yamamori, Ayano Mizobata, Yoshiro Saito, Yasuomi Urano, Osamu Inanami, Kaikobad Irani, Noriko Noguchi

    FREE RADICAL RESEARCH 45 (3) 342-350 2011/03

    DOI: 10.3109/10715762.2010.532496  

    ISSN: 1071-5762

  112. Correlation between saliva cortisol concentration and sympathovagal balance before sleep in young male subjects

    Yoshino Kohzoh, Saito Yoshiro, Jitousyo Mamiko, Yoshida Yasukazu

    Stress Science Research 26 48-52 2011

    Publisher: Public Health Research Foundation

    DOI: 10.5058/stresskagakukenkyu.26.48  

    ISSN: 1341-9986

    More details Close

    The aim of this study is to investigate the correlation between saliva cortisol concentration and balance of autonomic nervous system (sympathovagal balance) before sleep in normal male subjects. The subjects (N=27) intermittently wore an ambulatory wearable device that records heart rate variability (RR-interval) for three days during daily life. Their saliva was sampled at each night before sleep. The cortisol concentration of each sample was quantified. The sympathovagal balance was evaluated by calculating the normalized high-frequency power (HFnu) of RR-interval variability that was measured from A+5 to A minutes (A=0, 5,..., 55) before the saliva sampling time. The correlation coefficients between high values of saliva cortisol concentration and the corresponding natural logarithm of HFnu were from -0.40 to -0.49 (p=0.006-0.034) when the values of A were 10, 15, 20, and 25. This result implies that hypothalamic-pituitary-adrenal (HPA) axis activity before sleep is significantly correlated with dominance of sympathetic nervous system activity with time lag of 10-30 minutes during relatively high stress condition.<br>

  113. Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: Tocopherols and tocotrienols exert similar effects by antioxidant function

    Yoshiro Saito, Keiko Nishio, Yoko Ogawa Akazawa, Kazunori Yamanaka, Akiko Miyama, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 49 (10) 1542-1549 2010/11

    DOI: 10.1016/j.freeradbiomed.2010.08.016  

    ISSN: 0891-5849

  114. A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance

    Hirofumi Misu, Toshinari Takamura, Hiroaki Takayama, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Seiichiro Kurita, Kazuhide Ishikura, Hitoshi Ando, Yumie Takeshita, Tsuguhito Ota, Masaru Sakurai, Tatsuya Yamashita, Eishiro Mizukoshi, Taro Yamashita, Masao Honda, Ken-ichi Miyamoto, Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki, Han-Jong Kim, In-Kyu Lee, Yasuhiko Minokoshi, Yoshiro Saito, Kazuhiko Takahashi, Yoshihiro Yamada, Nobuyuki Takakura, Shuichi Kaneko

    CELL METABOLISM 12 (5) 483-495 2010/11

    DOI: 10.1016/j.cmet.2010.09.015  

    ISSN: 1550-4131

  115. Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: Tocopherols and tocotrienols exert similar effects by antioxidant function

    Yoshiro Saito, Keiko Nishio, Yoko Ogawa Akazawa, Kazunori Yamanaka, Akiko Miyama, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 49 (10) 1542-1549 2010/11

    DOI: 10.1016/j.freeradbiomed.2010.08.016  

    ISSN: 0891-5849

  116. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals

    Yoko Ogawa Akazawa, Yoshiro Saito, Takao Hamakubo, Yoshinori Masuo, Yasukazu Yoshida, Keiko Nishio, Mototada Shichiri, Tomohiro Miyasaka, Hiroko Iwanari, Yasuhiro Mochizuki, Tatsuhiko Kodama, Noriko Noguchi, Etsuo Niki

    NEUROSCIENCE LETTERS 483 (3) 201-205 2010/10

    DOI: 10.1016/j.neulet.2010.08.007  

    ISSN: 0304-3940

  117. Action of 6-amino-3-pyridinols as novel antioxidants against free radicals and oxidative stress in solution, plasma, and cultured cells

    Yo Omata, Yoshiro Saito, Yasukazu Yoshida, Byeong-Seon Jeong, Remigiusz Serwa, Tae-gyu Nam, Ned A. Porter, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 48 (10) 1358-1365 2010/05

    DOI: 10.1016/j.freeradbiomed.2010.02.018  

    ISSN: 0891-5849

  118. Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: Alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein

    Yoko Ogawa Akazawa, Yoshiro Saito, Keiko Nishio, Masanori Horie, Tomoya Kinumi, Yoshinori Masuo, Yasukazu Yoshida, Hitoshi Ashida, Etsuo Niki

    FREE RADICAL RESEARCH 44 (4) 410-421 2010/04

    DOI: 10.3109/10715760903536349  

    ISSN: 1071-5762

    eISSN: 1029-2470

  119. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C

    Yasukazu Yoshida, Yasuharu Imai, Yoshiyuki Sawai, Yoshiro Saito, Jiaofei Cao, Kazuto Fukuda, Etsuo Niki

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 25 (1) 107-115 2010/01

    DOI: 10.1111/j.1440-1746.2009.05928.x  

    ISSN: 0815-9319

  120. The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers

    Yasukazu Yoshida, Nanako Itoh, Mieko Hayakawa, Yoko Habuchi, Yoshiro Saito, Yoshitane Tsukamoto, Osamu Cynshi, Kou-ichi Jishage, Hiroyuki Arai, Etsuo Niki

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY 21 (1) 66-76 2010/01

    DOI: 10.1016/j.jnutbio.2008.10.006  

    ISSN: 0955-2863

  121. The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers

    Yasukazu Yoshida, Nanako Itoh, Mieko Hayakawa, Yoko Habuchi, Yoshiro Saito, Yoshitane Tsukamoto, Osamu Cynshi, Kou-ichi Jishage, Hiroyuki Arai, Etsuo Niki

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY 21 (1) 66-76 2010/01

    DOI: 10.1016/j.jnutbio.2008.10.006  

    ISSN: 0955-2863

  122. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C

    Yasukazu Yoshida, Yasuharu Imai, Yoshiyuki Sawai, Yoshiro Saito, Jiaofei Cao, Kazuto Fukuda, Etsuo Niki

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 25 (1) 107-115 2010/01

    DOI: 10.1111/j.1440-1746.2009.05928.x  

    ISSN: 0815-9319

  123. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients

    Yoshiro Saito, Takao Hamakubo, Yasukazu Yoshida, Yoko Ogawa, Yasuo Hara, Harutoshi Fujimura, Yasuharu Imai, Hiroko Iwanari, Yasuhiro Mochizuki, Mototada Shichiri, Keiko Nishio, Tomoya Kinumi, Noriko Noguchi, Tatsuhiko Kodama, Etsuo Niki

    NEUROSCIENCE LETTERS 465 (1) 1-5 2009/11

    DOI: 10.1016/j.neulet.2009.08.074  

    ISSN: 0304-3940

  124. Antioxidant action of sugar-pendant C-60 fullerenes

    Masanori Horie, Akiko Fukuhara, Yoshiro Saito, Yasukazu Yoshida, Hiroe Sato, Hiromi Ohi, Makoto Obata, Yuji Mikata, Shigenobu Yano, Etsuo Niki

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 19 (20) 5902-5904 2009/10

    DOI: 10.1016/j.bmcl.2009.08.067  

    ISSN: 0960-894X

  125. Antioxidant action of sugar-pendant C-60 fullerenes

    Masanori Horie, Akiko Fukuhara, Yoshiro Saito, Yasukazu Yoshida, Hiroe Sato, Hiromi Ohi, Makoto Obata, Yuji Mikata, Shigenobu Yano, Etsuo Niki

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 19 (20) 5902-5904 2009/10

    DOI: 10.1016/j.bmcl.2009.08.067  

    ISSN: 0960-894X

  126. Assessment of the antioxidant capacity of a fermented grain food product, Antioxidant Biofactor (AOB), by using pyranine and pyrogallol red as a combined probe

    Yo Omata, Yoko Ogawa, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    FOOD CHEMISTRY 114 (2) 429-433 2009/05

    DOI: 10.1016/j.foodchem.2008.09.066  

    ISSN: 0308-8146

  127. Characterization of cellular uptake and distribution of coenzyme Q(10) and vitamin E in PC12 cells

    Yoshiro Saito, Akiko Fukuhara, Keiko Nishio, Mieko Hayakawa, Yoko Ogawa, Hirokazu Sakamoto, Kenji Fujii, Yasukazu Yoshida, Etsuo Niki

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY 20 (5) 350-357 2009/05

    DOI: 10.1016/j.jnutbio.2008.04.005  

    ISSN: 0955-2863

  128. Characterization of cellular uptake and distribution of coenzyme Q(10) and vitamin E in PC12 cells

    Yoshiro Saito, Akiko Fukuhara, Keiko Nishio, Mieko Hayakawa, Yoko Ogawa, Hirokazu Sakamoto, Kenji Fujii, Yasukazu Yoshida, Etsuo Niki

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY 20 (5) 350-357 2009/05

    DOI: 10.1016/j.jnutbio.2008.04.005  

    ISSN: 0955-2863

  129. Assessment of the antioxidant capacity of a fermented grain food product, Antioxidant Biofactor (AOB), by using pyranine and pyrogallol red as a combined probe

    Yo Omata, Yoko Ogawa, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    FOOD CHEMISTRY 114 (2) 429-433 2009/05

    DOI: 10.1016/j.foodchem.2008.09.066  

    ISSN: 0308-8146

  130. Sustainable and practical degradation of intact chicken feathers by cultivating a newly isolated thermophilic Meiothermus ruber H328

    Tatsunobu Matsui, Yukie Yamada, Hideki Mitsuya, Yasushi Shigeri, Yasukazu Yoshida, Yoshiro Saito, Hiroshi Matsui, Kunihiko Watanabe

    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 82 (5) 941-950 2009/04

    DOI: 10.1007/s00253-009-1880-4  

    ISSN: 0175-7598

    eISSN: 1432-0614

  131. Protein Adsorption of Ultrafine Metal Oxide and Its Influence on Cytotoxicity toward Cultured Cells

    Masanori Horie, Keiko Nishio, Katsuhide Fujita, Shigehisa Endoh, Arisa Miyauchi, Yoshiro Saito, Hitoshi Iwahashi, Kazuhiro Yamamoto, Hideki Murayama, Haiime Nakano, Naoki Nanashima, Etsuo Niki, Yasukazu Yoshida

    CHEMICAL RESEARCH IN TOXICOLOGY 22 (3) 543-553 2009/03

    DOI: 10.1021/tx800289z  

    ISSN: 0893-228X

  132. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers

    Yasukazu Yoshida, Atsushi Yoshikawa, Tomoya Kinumi, Yoko Ogawa, Yoshiro Saito, Kazuyuki Ohara, Hirokazu Yamamoto, Yasuharu Imai, Etsuo Niki

    NEUROBIOLOGY OF AGING 30 (2) 174-185 2009/02

    DOI: 10.1016/j.neurobiolaging.2007.06.012  

    ISSN: 0197-4580

    eISSN: 1558-1497

  133. A gene expression profiling approach to study the influence of ultrafine particles on rat lungs

    Katsuhide Fujita, Yasuo Morimoto, Akira Ogami, Isamu Tanaka, Shigehisa Endoh, Kunio Uchida, Hiroaki Tao, Mikio Akasaka, Masaharu Inada, Kazuhiro Yamamoto, Hiroko Fukui, Mieko Hayakawa, Masanori Horie, Yoshiro Saito, Yasukazu Yoshida, Hitoshi Iwahashi, Etsuo Niki, Junko Nakanishi

    Atmospheric and Biological Environmental Monitoring 219-227 2009

    Publisher: Springer Netherlands

    DOI: 10.1007/978-1-4020-9674-7_14  

  134. Assessment of antioxidant capacity of fermented grain food product, Antioxidant Biofactor (AOB), by ORAC method and inhibition of lipid peroxidation

    斎藤 芳郎

    Food Chemistry (114) 429-433 2009

    DOI: 10.1016/j.foodchem.2008.09.066  

  135. Characterization of novel furan compounds on the basis of their radical scavenging activity and cytoprotective effects against glutamate- and lipopolysaccharide-induced insults

    Keiko Nishio, Akiko Fukuhara, Yo Omata, Yoshiro Saito, Shuuhei Yamaguchi, Hisatoyo Kato, Yasukazu Yoshida, Etsuo Niki

    BIOORGANIC & MEDICINAL CHEMISTRY 16 (24) 10332-10337 2008/12

    DOI: 10.1016/j.bmc.2008.10.038  

    ISSN: 0968-0896

  136. Induction of adaptive response and enhancement of PC12 cell tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation Peer-reviewed

    Yo Omata, Yoshiro Saito, Katsuhide Fujita, Yoko Ogawa, Keiko Nishio, Yasukazu Yoshida, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 45 (10) 1437-1445 2008/11

    DOI: 10.1016/j.freeradbiomed.2008.08.018  

    ISSN: 0891-5849

  137. Assessment of radical scavenging capacity and lipid peroxidation inhibiting capacity of antioxidant

    Etsuo Niki, Yo Omata, Akiko Fukuhara, Yoshiro Saito, Yasukazu Yoshida

    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 56 (18) 8255-8260 2008/09

    DOI: 10.1021/jf800605x  

    ISSN: 0021-8561

  138. Effect of oxygen concentration on free radical-induced cytotoxicity

    Zhi-Hua Chen, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY 72 (6) 1491-1497 2008/06

    DOI: 10.1271/bbb.80002  

    ISSN: 0916-8451

    eISSN: 1347-6947

  139. Simple assessment of radical scavenging capacity of beverages

    Yo Omata, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 56 (9) 3386-3390 2008/05

    DOI: 10.1021/jf703771v  

    ISSN: 0021-8561

  140. Antioxidant capacity of BO-653, 2,3-dihydro-5-hydroxy-4, 6-di-tert-butyl-2,2-dipentylbenzofuran, and uric acid as evaluated by ORAC method and inhibition of lipid peroxidation

    Etsuo Niki, Akiko Fukuhara, Yo Omata, Yoshiro Saito, Yasukazu Yoshida

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 18 (7) 2464-2466 2008/04

    DOI: 10.1016/j.bmcl.2008.02.038  

    ISSN: 0960-894X

  141. Novel finding regarding cholesterol oxidation: Cholesterol is more susceptible to oxidation than linoleates in cultured cells under oxidative stress.

    斎藤 芳郎

    International Arteriosclerosis Society (IAS) commentaries 2008

  142. Induction of Adaptive Response and Enhancement of PC12 Cell Tolerance by Lipopolysaccharide Primarily Through the Upregulation of Glutathione S-Transferase A3 Via Nrf2 Activation

    Yoshiro Saito, Yo Omata, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 45 (45) S37-S37 2008

    DOI: 10.1016/j.freeradbiomed.2008.08.018  

    ISSN: 0891-5849

  143. gamma-tocopheryl quinone, not alpha-tocopheryl quinone, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4

    Yoko Ogawa, Yoshiro Saito, Keiko Nishio, Yasukazu Yoshida, Hitoshi Ashida, Etsuo Niki

    FREE RADICAL RESEARCH 42 (7) 674-U17 2008

    DOI: 10.1080/10715760802277396  

    ISSN: 1071-5762

  144. Regulation of GCL activity and cellular glutathione through inhibition of ERK phosphorylation

    Zhi-Hua Chen, Yoshiro Saito, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    BIOFACTORS 33 (1) 1-11 2008

    DOI: 10.1002/biof.5520330101  

    ISSN: 0951-6433

  145. Chemical reactivities and physical effects in comparison between tocopherols and tocotrienols: Physiological significance and prospects as antioxidants

    Yasukazu Yoshida, Yoshiro Saito, Leslie Sargent Jones, Yasushi Shigeri

    JOURNAL OF BIOSCIENCE AND BIOENGINEERING 104 (6) 439-445 2007/12

    DOI: 10.1263/jbb.104.439  

    ISSN: 1389-1723

    eISSN: 1347-4421

  146. Cholesterol is more susceptible to oxidation than linoleates in cultured cells under oxidative stress induced by selenium deficiency and free radicals

    Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    FEBS LETTERS 581 (22) 4349-4354 2007/09

    DOI: 10.1016/j.febslet.2007.08.010  

    ISSN: 0014-5793

  147. Protective effects of 15-deoxy-Delta(12,14)-prostaglandin J(2) against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione

    Yoshiro Saito, Keiko Nishio, Yumiko Numakawa, Yoko Ogawa, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    JOURNAL OF NEUROCHEMISTRY 102 (5) 1625-1634 2007/09

    DOI: 10.1111/j.1471-4159.2007.04701.x  

    ISSN: 0022-3042

  148. Levels of lipid peroxidation in human plasma and erythrocytes: Comparison between fatty acids and cholesterol

    Yasukazu Yoshida, Yoshiro Saito, Mieko Hayakawa, Yoko Habuchi, Yasuharu Imai, Yoshiyuki Sawai, Etsuo Niki

    LIPIDS 42 (5) 439-449 2007/05

    DOI: 10.1007/s11745-007-3037-5  

    ISSN: 0024-4201

  149. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action

    Yoshiro Saito, Keiko Nishio, Yoko Ogawa, Tomoya Kinumi, Yasukazu Yoshida, Yoshinori Masuo, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 42 (5) 675-685 2007/03

    DOI: 10.1016/j.freeradbiomed.2006.12.004  

    ISSN: 0891-5849

  150. Assessment of antioxidative activity of extract from fermented grain food mixture using chemical and cellular systems

    Yoko Ogawa, Yo Omata, Keiko Nishio, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    BIOFACTORS 31 (3-4) 237-248 2007

    ISSN: 0951-6433

  151. Cytotoxic effects of various stressors on PC12 cells: Involvement of oxidative stress and effect of antioxidants

    Rosaria Piga, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    NEUROTOXICOLOGY 28 (1) 67-75 2007/01

    DOI: 10.1016/j.neuro.2006.07.006  

    ISSN: 0161-813X

  152. Assessment of antioxidative activity of extract from fermented grain food mixture using chemical and cellular systems Peer-reviewed

    Yoko Ogawa, Yo Omata, Keiko Nishio, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    BIOFACTORS 31 (3-4) 237-248 2007

    DOI: 10.1002/biof.5520310311  

    ISSN: 0951-6433

  153. Turning point in apoptosis/necrosis induced by hydrogen peroxide

    Yoshiro Saito, Keiko Nishio, Yoko Ogawa, Junko Kimata, Tomoya Kinumi, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL RESEARCH 40 (6) 619-630 2006/06

    DOI: 10.1080/10715760600632552  

    ISSN: 1071-5762

    eISSN: 1029-2470

  154. Induction of Adaptive Response and Enhancement of PC12 Cell Tolerance by 7-Hydroxycholesterol and 15-Deoxy-Delta(12,14)-Prostaglandin J(2) through Up-regulation of Cellular Glutathione via Different Mechanisms

    Zhi-Hua Chen, Yasukazu Yoshida, Yoshiro Saito, Azusa Sekine, Noriko Noguchi, Etsuo Niki

    JOURNAL OF BIOLOGICAL CHEMISTRY 281 (20) 14440-14445 2006/05

    DOI: 10.1074/jbc.M600260200  

    ISSN: 0021-9258

  155. Adaptive response induced by lipid peroxidation products in cell cultures

    ZH Chen, Y Yoshida, Y Saito, N Noguchi, E Niki

    FEBS LETTERS 580 (2) 479-483 2006/01

    DOI: 10.1016/j.febslet.2005.12.045  

    ISSN: 0014-5793

  156. Lipid peroxidation: Mechanisms, inhibition, and biological effects

    E Niki, Y Yoshida, Y Saito, N Noguchi

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 338 (1) 668-676 2005/12

    DOI: 10.1016/j.bbrc.2005.08.072  

    ISSN: 0006-291X

  157. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2

    ZH Chen, Y Saito, Y Yoshida, A Sekine, N Noguchi, E Niki

    JOURNAL OF BIOLOGICAL CHEMISTRY 280 (51) 41921-41927 2005/12

    DOI: 10.1074/jbc.M508556200  

    ISSN: 0021-9258

  158. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL

    T Kinumi, Y Ogawa, J Kimata, Y Saito, Y Yoshida, E Niki

    FREE RADICAL RESEARCH 39 (12) 1335-1344 2005/12

    DOI: 10.1080/10715760500306695  

    ISSN: 1071-5762

  159. Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage

    ZH Chen, Y Yoshida, Y Saito, E Niki

    NEUROSCIENCE LETTERS 383 (3) 256-259 2005/08

    DOI: 10.1016/j.neulet.2005.04.022  

    ISSN: 0304-3940

  160. Cytotoxic effect of formaldehyde with free radicals via increment of cellular reactive oxygen species

    Y Saito, K Nishio, Y Yoshida, E Niki

    TOXICOLOGY 210 (2-3) 235-245 2005/06

    DOI: 10.1016/j.tox.2005.02.006  

    ISSN: 0300-483X

  161. Characterization of monochloramine toxicity on PC12 cells and protective effect of tocopherol via antioxidative function

    R Piga, Y Saito, ZH Chen, Y Yoshida, E Niki

    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 436 (1) 101-109 2005/04

    DOI: 10.1016/j.abb.2005.01.021  

    ISSN: 0003-9861

  162. Domain structure of bi-functional selenoprotein P

    Y Saito, N Sato, M Hirashima, G Takebe, S Nagasawa, E Niki, K Takahashi

    Natural Antioxidants and Micronutrients 105-108 2005

  163. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells

    S Maehara, S Tanaka, M Shimada, K Shirabe, Y Saito, K Takahashi, Y Maehara

    INTERNATIONAL JOURNAL OF CANCER 112 (2) 184-189 2004/11

    DOI: 10.1002/ijc.20304  

    ISSN: 0020-7136

  164. Domain structure of bi-functional selenoprotein P

    Y Saito, N Sato, M Hirashima, G Takebe, S Nagasawa, K Takahashi

    BIOCHEMICAL JOURNAL 381 (381) 841-846 2004/08

    DOI: 10.1042/BJ20040328  

    ISSN: 0264-6021

  165. Effects of a novel gaseous antioxidative system containing a rosemary extract on the oxidation induced by nitrogen dioxide and ultraviolet radiation

    Y Saito, A Shiga, Y Yoshida, T Furuhashi, Y Fujita, E Niki

    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY 68 (4) 781-786 2004/04

    DOI: 10.1271/bbb.68.781  

    ISSN: 0916-8451

    eISSN: 1347-6947

  166. Application of water-soluble radical initiator, 2,2 '-azobis-[2-(2-imidazolin-2-yl)propane] dihydrochloride, to a study of oxidative stress

    Y Yoshida, N Itoh, Y Saito, M Hayakawa, E Niki

    FREE RADICAL RESEARCH 38 (4) 375-384 2004/04

    DOI: 10.1080/1071576042000191763  

    ISSN: 1071-5762

  167. DJ-1 has a role in antioxidative stress to prevent cell death (vol 5, pg 213, 2004)

    T Taira, Y Saito, T Niki, SMM Iguchi-Ariga, K Takahashi, H Ariga

    EMBO REPORTS 5 (4) 430-430 2004/04

    DOI: 10.1038/sj.embor.7400143  

    ISSN: 1469-221X

  168. DJ-1 has a role in antioxidative stress to prevent cell death

    T Taira, Y Saito, T Niki, SMM Iguchi-Ariga, K Takahashi, H Ariga

    EMBO REPORTS 5 (2) 213-218 2004/02

    DOI: 10.1038/sj.embor.7400074  

    ISSN: 1469-221X

  169. Effects of Volatile Constituents of the Rosemary Extract on the Oxidation Caused by Ultraviolet Radiation and Nitrogen Dioxide

    斎藤 芳郎

    Aroma Research (18) 118-122 2004

  170. Characterization of cellular uptake and distribution of vitamin E

    Y Saito, Y Yoshida, K Nishio, M Hayakawa, E Niki

    VITAMIN E AND HEALTH 1031 (1031) 368-375 2004

    DOI: 10.1196/annals.1331.047  

    ISSN: 0077-8923

  171. Cell death caused by selenium deficiency and protective effect of antioxidants

    Y Saito, Y Yoshida, T Akazawa, K Takahashi, E Niki

    JOURNAL OF BIOLOGICAL CHEMISTRY 278 (41) 39428-39434 2003/10

    DOI: 10.1074/jbc.M305542200  

    ISSN: 0021-9258

  172. Identification of selenoprotein P fragments as a cell-death inhibitory factor

    M Hirashima, T Naruse, H Maeda, C Nozaki, Y Saito, K Takahashi

    BIOLOGICAL & PHARMACEUTICAL BULLETIN 26 (6) 794-798 2003/06

    DOI: 10.1248/bpb.26.794  

    ISSN: 0918-6158

  173. Identification of selenoprotein P fragments as a cell-death inhibitory factor Peer-reviewed

    M Hirashima, T Naruse, H Maeda, C Nozaki, Y Saito, K Takahashi

    BIOLOGICAL & PHARMACEUTICAL BULLETIN 26 (6) 794-798 2003/06

    DOI: 10.1248/bpb.26.794  

    ISSN: 0918-6158

  174. Identification of selenoprotein P fragments as a cell-death inhibitory factor

    Masaki Hirashima, Takeshi Naruse, Hiroaki Maeda, Chikateru Nozaki, Yoshiro Saito, Kazuhiko Takahashi

    Biological and Pharmaceutical Bulletin 26 (6) 794-798 2003

    Publisher: Pharmaceutical Society of Japan

    DOI: 10.1248/bpb.26.794  

    ISSN: 0918-6158

  175. Characterization of selenoprotein P as a selenium supply protein

    Y Saito, K Takahashi

    EUROPEAN JOURNAL OF BIOCHEMISTRY 269 (22) 5746-5751 2002/11

    DOI: 10.1046/j.1432-1033.2002.03298.x  

    ISSN: 0014-2956

  176. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P

    G Takebe, J Yarimizu, Y Saito, T Hayashi, H Nakamura, J Yodoi, S Nagasawa, K Takahashi

    JOURNAL OF BIOLOGICAL CHEMISTRY 277 (43) 41254-41258 2002/10

    DOI: 10.1074/jbc.M202773200  

    ISSN: 0021-9258

  177. Production and application of monoclonal antibodies to human selenoprotein P

    Y Saito, Y Watanabe, E Saito, T Honjoh, K Takahashi

    JOURNAL OF HEALTH SCIENCE 47 (4) 346-352 2001/08

    DOI: 10.1248/jhs.47.346  

    ISSN: 1344-9702

  178. Structure and function of human selenoprotein P Peer-reviewed

    K Takahashi, Y Saito

    SEIKAGAKU 73 (4) 261-264 2001/04

    ISSN: 0037-1017

  179. Selenoprotein P: Its structure and functions Peer-reviewed

    Y. Saito, K. Takahashi

    Journal of Health Science 46 (6) 409-413 2000

    Publisher: Pharmaceutical Society of Japan

    DOI: 10.1248/jhs.46.409  

    ISSN: 1344-9702

  180. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase - Isolation and enzymatic characterization of human selenoprotein P

    Y Saito, T Hayashi, A Tanaka, Y Watanabe, M Suzuki, E Saito, K Takahashi

    JOURNAL OF BIOLOGICAL CHEMISTRY 274 (5) 2866-2871 1999/01

    DOI: 10.1074/jbc.274.5.2866  

    ISSN: 0021-9258

Show all ︎Show first 5

Misc. 126

  1. 過酸化水素によるATPの減少はAMPKの活性化を介してSelenoprotein Pの発現を抑制する。

    三田雄一郎, 細川萩月, 斎藤芳郎, 野口範子

    日本酸化ストレス学会学術集会プログラム・抄録集 77th 2024

  2. パーキンソン病で増加するDJ-1の翻訳後修飾に53番目のシステインが関与する

    松田康平, 三田雄一郎, 浦野泰臣, 西郷和真, 斎藤芳郎, 野口範子

    日本酸化ストレス学会学術集会プログラム・抄録集 77th 2024

  3. 肝蔵のフェロトーシス感受性におけるセレノプロテインP発現の意義

    名取萌花, 有澤琴子, 斎藤芳郎

    次世代を担う若手のためのファーマ・バイオフォーラム講演要旨集 21st 2022

  4. グリオブラストーマ治療標的としてのSeP/ApoER2経路

    杉浦ひかり, 清水未崎, 金子尚志, 外山喬士, 斎藤芳郎

    次世代を担う若手のためのファーマ・バイオフォーラム講演要旨集 21st 2022

  5. 細胞外基質ネフロネクチンはCD4+T細胞内の活性酸素種(ROS)介したTh17/Tregバランス制御により自己免疫疾患増悪化に関与する

    本田 真知子, 斎藤 芳郎, 今 重之

    日本薬学会年会要旨集 141年会 27P02-130 2021/03

    Publisher: (公社)日本薬学会

    ISSN: 0918-9823

  6. 【食と健康を結ぶメディカルサイエンス 生体防御系を亢進し、健康の維持に働く分子機構】(第2章)食による生体防御系の活性化 抗酸化 セレノプロテインの機能と疾患 食とセレンの代謝

    斎藤 芳郎

    実験医学 38 (10) 1654-1662 2020/06

    Publisher: (株)羊土社

    ISSN: 0288-5514

  7. 硫黄代謝研究の最前線が切り拓く毒性学 セレン-硫黄代謝の接点およびクロストーク 生体内における識別とその制御

    斎藤 芳郎

    The Journal of Toxicological Sciences 45 (Suppl.) S15-S15 2020/06

    Publisher: (一社)日本毒性学会

    ISSN: 0388-1350

    eISSN: 1880-3989

  8. ミクログリアにおけるメチル水銀によるMAPキナーゼを介したTNF-α発現誘導機構

    外山 喬士, 星 尚志, 斎藤 芳郎, 永沼 章, 黄 基旭

    The Journal of Toxicological Sciences 45 (Suppl.) S129-S129 2020/06

    Publisher: (一社)日本毒性学会

    ISSN: 0388-1350

    eISSN: 1880-3989

  9. マウス脳内におけるTNF受容体3の発現細胞特定およびメチル水銀による中枢神経障害における役割の解明

    角田 洋平, 外山 喬士, 永沼 章, 斎藤 芳郎, 黄 基旭

    The Journal of Toxicological Sciences 45 (Suppl.) S134-S134 2020/06

    Publisher: (一社)日本毒性学会

    ISSN: 0388-1350

    eISSN: 1880-3989

  10. セレン含有タンパク質セレノプロテインPのセレン運搬活性における受容体ApoER2バリアントの関与

    水野 彩子, 堤 良平, 斎藤 芳郎

    日本薬学会年会要旨集 140年会 26P-am155S 2020/03

    Publisher: (公社)日本薬学会

    ISSN: 0918-9823

  11. ビタミンE類の多様な抗酸化作用 アイソフォームによる細胞保護メカニズムの違い

    斎藤 芳郎

    ビタミン 94 (2) 59-70 2020/02

    Publisher: (公社)日本ビタミン学会

    ISSN: 0006-386X

  12. ホメオスタシスにおける活性酸素の功罪 生活習慣病と抗酸化タンパク質セレノプロテインP

    斎藤 芳郎

    日本運動生理学雑誌 26 (2) 45-49 2019/12

    Publisher: 日本運動生理学会

    ISSN: 1340-3036

  13. 角層DJ-1を用いた体内の酸化ストレス評価

    高橋 理子, 鈴木 民恵, 石渡 潮路, 村上 礼一, 秋田 美季, 宮川 泰子, 三上 正治, 八代 壇, 斎藤 芳郎, 野口 範子, 松熊 祥子

    加齢皮膚医学セミナー 14 (2) 70-70 2019/12

    Publisher: 加齢皮膚医学研究会

  14. セレノプロテインPの機能と疾患 疾患バイオマーカーとしての可能性

    斎藤 芳郎

    生化学 91 (5) 686-690 2019/10

    Publisher: (公社)日本生化学会

    ISSN: 0037-1017

  15. ビタミンE類の多様な抗酸化作用 必須微量元素セレンとの関わり

    斎藤 芳郎

    ビタミン 93 (9) 424-424 2019/09

    Publisher: (公社)日本ビタミン学会

    ISSN: 0006-386X

  16. 生体エネルギーと電子共役の複雑性制御 生体内におけるセレン代謝とエネルギー産生

    斎藤 芳郎

    日本生化学会大会プログラム・講演要旨集 92回 [2S18m-02] 2019/09

    Publisher: (公社)日本生化学会

  17. 革新的治療法を生み出すセレノプロテイン研究 抗酸化ヘパトカイン"セレノプロテインP"が惹起する全身の糖尿病関連病態

    高山 浩昭, 御簾 博文, 斎藤 芳郎, 篁 俊成

    日本生化学会大会プログラム・講演要旨集 92回 [3S15m-01] 2019/09

    Publisher: (公社)日本生化学会

  18. 革新的治療法を生み出すセレノプロテイン研究 肺動脈性肺高血圧症の新しい治療標的 セレノプロテインP

    佐藤 公雄, 菊地 順裕, 斎藤 芳郎, 下川 宏明

    日本生化学会大会プログラム・講演要旨集 92回 [3S15m-02] 2019/09

    Publisher: (公社)日本生化学会

  19. 角層DJ-1を用いた体内の酸化ストレス評価

    高橋 理子, 鈴木 民恵, 石渡 潮路, 村上 礼一, 秋田 美季, 宮川 泰子, 三上 正治, 八代 壇, 斎藤 芳郎, 野口 範子, 松熊 祥子

    加齢皮膚医学セミナー 14 (1) 49-57 2019/06

    Publisher: 加齢皮膚医学研究会

  20. 角層DJ-1を用いた体内の酸化ストレス評価

    高橋 理子, 鈴木 民恵, 石渡 潮路, 村上 礼一, 秋田 美季, 宮川 泰子, 三上 正治, 八代 壇, 斎藤 芳郎, 野口 範子, 松熊 祥子

    加齢皮膚医学セミナー 14 (1) 68-68 2019/06

    Publisher: 加齢皮膚医学研究会

  21. 革新的なレドックス研究から見えてきた生命科学の新世紀 血漿セレン含有タンパク質セレノプロテインPによるレドックス制御メカニズムおよびその破綻と糖尿病

    斎藤 芳郎

    日本生化学会大会プログラム・講演要旨集 91回 [2S08m-07] 2018/09

    Publisher: (公社)日本生化学会

  22. パーキンソン病のバイオマーカーへの期待

    鈴木 則宏, 斎藤 芳郎, 関 守信, 徳田 隆彦

    Frontiers in Parkinson Disease 11 (2) 63-75 2018/06

    Publisher: (株)メディカルレビュー社

    ISSN: 1883-0331

  23. Serenoprotein P中和抗体を用いた糖尿病治療の開発

    三田 雄一郎, 中山 華穂, 稲荷 尚吾, 野口 範子, 斎藤 芳郎

    日本内分泌学会雑誌 94 (1) 360-360 2018/04

    Publisher: (一社)日本内分泌学会

    ISSN: 0029-0661

    eISSN: 2186-506X

  24. インスリン抵抗性の病態から治療への展開 ヘパトカインセレノプロテインPを標的とするインスリン抵抗性治療薬の開発を目指して

    御簾 博文, 三田 雄一郎, 斎藤 芳郎, 篁 俊成

    糖尿病 61 (Suppl.1) S-29 2018/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  25. インスリン抵抗性の病態から治療への展開 ヘパトカインセレノプロテインPを標的とするインスリン抵抗性治療薬の開発を目指して

    御簾 博文, 三田 雄一郎, 斎藤 芳郎, 篁 俊成

    糖尿病 61 (Suppl.1) S-29 2018/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

  26. 発見から200年を迎えた必須微量元素セレン研究の最前線 セレノプロテインPのセレン運搬作用と膵β細胞のレドックス制御

    斎藤 芳郎

    日本薬学会年会要旨集 138年会 (1) 221-221 2018/03

    Publisher: (公社)日本薬学会

    ISSN: 0918-9823

  27. 【レドックス疾患学 酸素・窒素・硫黄活性種はどう作用するのか、どこまで健康・疾患と関わるのか?】 (第2章)レドックスと疾患 セレノプロテインPによるレドックス制御と2型糖尿病

    斎藤 芳郎, 野口 範子, 御簾 博文, 篁 俊成

    実験医学 36 (5) 753-759 2018/03

    Publisher: (株)羊土社

    ISSN: 0288-5514

  28. 膵β細胞モデルMIN6はセレノプロテインP発現を介して抗酸化システムを維持する

    中尾 昌平, 三田 雄一郎, 斎藤 芳郎, 野口 範子

    生命科学系学会合同年次大会 2017年度 [2P-0374] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  29. 膵β細胞モデルMIN6における過剰Selenoprotein Pによるセレン運搬作用を介したERストレス誘導メカニズムの解析

    長村 尭浩, 稲荷 尚吾, 三田 雄一郎, 野口 範子, 斎藤 芳郎

    生命科学系学会合同年次大会 2017年度 [2P-1003] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  30. non-coding RNAによるSelenoprotein P翻訳抑制メカニズムの解析

    三田 雄一郎, 斎藤 芳郎, 内田 理沙, 安原 小百合, 横大路 将, 野口 範子

    生命科学系学会合同年次大会 2017年度 [3P-0671] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  31. 糖尿病関連タンパク質Selenoprotein Pの翻訳を抑制する内在性long non-coding RNAの発現変化

    内田 理沙, 三田 雄一郎, 横大路 将, 安原 小百合, 斎藤 芳郎, 野口 範子

    生命科学系学会合同年次大会 2017年度 [3P-0672] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  32. 必須微量元素"セレン"の生物学と医学-発見から200年を迎えて 血漿セレン含有タンパク質セレノプロテインPの機能と疾患 レドックスバランスと膵β細胞の機能

    斎藤 芳郎

    生命科学系学会合同年次大会 2017年度 [4PW24-4] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  33. ヒト皮膚細胞モデルHaCaTにおけるDJ-1誘導因子の同定および酸化ストレス防御効果の評価

    安藤 万由, 斎藤 芳郎, 石渡 潮路, 松熊 祥子, 野口 範子

    生命科学系学会合同年次大会 2017年度 [4AT18-0506)] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  34. P210型BCR‐ABL PHドメインのリガンド特性およびその病理的意義の解明

    島崎健太朗, 高橋美帆, 梅田真郷, 舟本聡, 斎藤芳郎, 野口範子, 熊谷圭吾, 花田賢太郎, 塚原富士子, 丸義朗, 柴田識人, 内藤幹彦, 内藤幹彦, 西川喜代孝

    日本生化学会大会(Web) 2017年度 [1PT26-0039)] 2017/12

    Publisher: 生命科学系学会合同年次大会運営事務局

  35. Decrease of Insulin Secretion is Induced by Excess Selenoprotein P-Improving Effects of Neutralizing Antibody

    Yoshiro Saito, Yuichiro Mita, Kaho Nakayama, Shogo Inari, Takahiro Nagamura, Noriko Noguchi

    FREE RADICAL BIOLOGY AND MEDICINE 112 156-156 2017/11

    DOI: 10.1016/j.freeradbiomed.2017.10.239  

    ISSN: 0891-5849

    eISSN: 1873-4596

  36. Interleukin-27 Induces p47(phox) in Monocyte-derived Macrophages and Dendritic cells and Enhances the Potential of Reactive Oxygen Species Generation

    Yoshiro Saito, Bharatwaj Sowrirajan, Deepak Poudyal, Noriko Noguchi, Harry L. Malech, H. Clifford Lane, Tomozumi Imamichi

    FREE RADICAL BIOLOGY AND MEDICINE 112 210-210 2017/11

    DOI: 10.1016/j.freeradbiomed.2017.10.334  

    ISSN: 0891-5849

    eISSN: 1873-4596

  37. ヒト血中ヘパトカインレベルの日内、摂食および75g糖負荷後の変動

    毛利 研祐, 御簾 博文, 圓山 泰史, 高山 浩昭, 竹下 有美枝, 斎藤 芳郎, 篁 俊成

    糖尿病 60 (Suppl.1) S-159 2017/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  38. エイコサペンタエン酸内服が2型糖尿病患者のインスリン感受性と血中セレノプロテインP濃度に及ぼす効果

    寺村 千里, 御簾 博文, 高山 浩昭, 斎藤 芳郎, 井川 寛章, 木谷 佐央理, 中川 浩実, 田中 健雄, 島 孝佑, 竹下 有美枝, 篁 俊成

    糖尿病 60 (Suppl.1) S-238 2017/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  39. メトホルミンの治療効果を予知する新規バイオマーカーとしてのセレノプロテインPの可能性

    金森 岳広, 御簾 博文, 田中 睦, 斉藤 芳郎, 齋藤 麗奈, 毛利 研祐, 竹下 有美枝, 篁 俊成

    糖尿病 59 (Suppl.1) S-139 2016/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  40. ヒト血中ヘパトカインレベルの日内、摂食後および75g糖負荷後の変動

    毛利 研祐, 御簾 博文, 高山 浩昭, 竹下 有美枝, 田中 睦, 斎藤 芳郎, 篁 俊成

    糖尿病 59 (Suppl.1) S-140 2016/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  41. セレノプロテインPの阻害抗体による糖尿病治療効果の解析 インスリン抵抗性および分泌能を改善する抗体医薬の開発

    三田 雄一郎, 中山 華穂, 稲荷 尚吾, 西藤 有希奈, 吉岡 佑弥, 曽谷 奏, 高部 稚子, 御簾 博文, 篁 俊成, 高橋 和彦, 野口 範子, 斎藤 芳郎

    糖尿病 59 (Suppl.1) S-444 2016/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

  42. Selenoprotein Pの中和抗体による耐糖能異常及びインスリン分泌能の改善

    三田雄一郎, 三田雄一郎, 中山華穂, 稲荷尚吾, 吉岡佑弥, 高部稚子, 御簾博文, 篁俊成, 野口範子, 斎藤芳郎

    日本酸化ストレス学会学術集会プログラム・抄録集 69th 2016

  43. セレノプロテインPの阻害抗体による糖尿病治療効果の解析-インスリン抵抗性および分泌能を改善する抗体医薬の開発

    三田雄一郎, 中山華穂, 稲荷尚吾, 西藤有希奈, 吉岡佑弥, 曽谷奏, 高部稚子, 御簾博文, 篁俊成, 高橋和彦, 野口範子, 斎藤芳郎

    糖尿病(Web) 59 (Suppl) 2016

    ISSN: 1881-588X

  44. Biology of selenium : molecular function of selenoproteins and related diseases

    斎藤 芳郎

    細胞工学 = Cell technology 35 (3) 240-246 2016

    Publisher: 学研メディカル秀潤社 ; 1982-2016

    ISSN: 0287-3796

  45. 膵臓β細胞モデルMIN6は過剰なSelenoprotein Pにより障害を受ける

    稲荷 尚吾, 高部 稚子, 三田 雄一郎, 御簾 博文, 篁 俊成, 野口 範子, 斎藤 芳郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 88回・38回 [4T特L-10(3P1201)] 2015/12

    Publisher: (公社)日本生化学会

  46. SBP2変異によるセレン含有タンパク質欠乏患者におけるコレステロールの酸化-細胞膜と血漿リポタンパク質の酸化反応の違い

    齋藤 芳郎, 七里 元督, 濱島 崇, 萩原 義久, 吉田 康一, 野口 範子

    脂質生化学研究 57 146-149 2015/05

    Publisher: 日本脂質生化学会

    ISSN: 0285-1520

  47. ヘパトカインセレノプロテインP血中濃度測定によるメトホルミンの治療効果予知

    毛利 研祐, 御簾 博文, 田中 睦, 斎藤 芳郎, 竹下 有美枝, 斎藤 麗奈, 金森 岳広, 金子 周一, 篁 俊成

    糖尿病 58 (Suppl.1) S-271 2015/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  48. ヘパトカインセレノプロテインP血中濃度による運動療法抵抗性の予知に関する検討

    御簾 博文, 田中 睦, 斎藤 芳郎, 石井 清朗, 竹下 有美枝, 金森 岳広, 赤澤 暢彦, 前田 清司, 竹越 一博, 金子 周一, 篁 俊成

    糖尿病 58 (Suppl.1) S-390 2015/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  49. 2型糖尿病患者におけるメトホルミンの血糖低下能に関するヘパトカインセレンタンパク質Pの血中濃度による予測(Blood levels of hepatokine selenoprotein P predict glucose-lowering effects of metformin in patients with type 2 diabetes)

    Mohri Kensuke, Misu Hirofumi, Tanaka Mutsumi, Saito Yoshiro, Takeshita Yumie, Kanamori Takehiro, Saito Reina, Kaneko Shuichi, Takamura Toshinari

    糖尿病 58 (Suppl.1) S-472 2015/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

  50. Novel Method for Suppression of Neuronal Cell Death by 24S-Hydroxycholesterol

    55 (4) 59-62 2015/01

    Publisher: 同志社大学理工学研究所

    ISSN: 0036-8172

  51. 1-I-11 血漿セレン含有タンパク質セレノプロテインPを標的とした2型糖尿病の抗体医薬の開発(一般演題要旨,ビタミン・バイオファクター研究のさらなる魅力~大和まほろぱからの発信~,第67回大会講演要旨)

    斎藤 芳郎, 中山 華穂, 三田 雄一郎, 野口 範子

    ビタミン 89 (4) 214-214 2015

    Publisher: 公益社団法人 日本ビタミン学会

    ISSN: 0006-386X

  52. Identification of neuron-derived protecting factors against oxidative stress

    野口 範子, 斎藤 芳郎

    コスメトロジー研究報告 23 61-64 2015

    Publisher: コスメトロジー研究振興財団

    ISSN: 2188-563X

  53. Enhancement of Oxidative Stress and Its Amelioration by Vitamin E in a Subject with Mutations in the Selenocysteine Insertion Sequence-Binding Protein 2 (SBP2) Gene

    Yoshiro Saito, Mototada Shichiri, Takashi Hamajima, Noriko Noguchi

    FREE RADICAL BIOLOGY AND MEDICINE 76 S90-S90 2014/11

    DOI: 10.1016/j.freeradbiomed.2014.10.314  

    ISSN: 0891-5849

    eISSN: 1873-4596

  54. 血中oxDJ-1の異常高値を示し、幻覚を認めたPDの4例

    西郷 和真, 斎藤 芳郎, 小川 郁子, 細井 幸恵, 三井 良之, 花田 一志, 上田 昌美, 石井 一成, 野口 範子, 楠 進

    Dementia Japan 28 (4) 504-504 2014/10

    Publisher: (一社)日本認知症学会

    ISSN: 1342-646X

  55. 血中酸化型DJ‐1異常高値の臨床的意義

    西郷和真, 斎藤芳郎, 小川郁子, 細井幸恵, 三井良之, 花田一志, 上田昌美, 石井一成, 野口範子, 楠進

    日本酸化ストレス学会学術集会プログラム・抄録集 67th 52 2014/08/29

  56. セレンタンパク質研究の最前線 血漿セレノプロテインPによるセレン代謝制御と2型糖尿病

    斎藤 芳郎, 吉岡 佑弥, 三田 雄一郎, 御簾 博文, 田中 睦, 篁 俊成, 野口 範子

    Biomedical Research on Trace Elements 25 (2) 50-50 2014/06

    Publisher: 日本微量元素学会

    ISSN: 0916-717X

  57. 脂肪肝患者におけるヘパトカインセレノプロテインP血中濃度と臓器別インスリン感受性の関連

    加藤 健一郎, 御簾 博文, 田中 睦, 斎藤 芳郎, 竹下 有美枝, 金子 周一, 篁 俊成

    糖尿病 57 (Suppl.1) S-251 2014/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  58. 脳特異的オキシステロール24S-hydroxycholesterolによる細胞死メカニズムの解析

    浦野泰臣, 山中一哲, 高部稚子, 斎藤芳郎, 野口範子

    日本Cell Death学会学術集会プログラム抄録集 23rd 2014

  59. 酸化コレステロール24S-OHCにより誘導されるNecroptosisのメカニズム

    高部稚子, 山中一哲, 浦野泰臣, 斎藤芳郎, 野口範子

    日本酸化ストレス学会学術集会プログラム・抄録集 67th 2014

  60. Investigation of Antioxidants Against Neuronal Cell Death Induced by Glutamate and Its Molecular Mechanisms

    斎藤 芳郎

    同志社大学理工学研究報告 54 (4) 11-15 2014/01

    Publisher: 同志社大学理工学研究所

    ISSN: 0036-8172

  61. Molecular Mechanisms of Neuronal Cell Death Induced by 24S-hydroxycholesterol

    斎藤 芳郎

    同志社大学理工学研究報告 54 (4) 16-20 2014/01

    Publisher: 同志社大学理工学研究所

    ISSN: 0036-8172

  62. Study on Involvement of Reactive Oxygen Species in Neuronal Cell Death Induced by Oxidation Product of Cholesterol

    野口 範子, 斎藤 芳郎, 浦野 泰臣

    同志社大学理工学研究報告 54 (4) 21-25 2014/01

    Publisher: 同志社大学理工学研究所

    ISSN: 0036-8172

  63. Circulating levels of selenoprotein P predict future hyperglycaemia in non-diabetic Japanese people

    H. Misu, T. Kanamori, Y. Takeshita, Y. Saito, M. Tanaka, S. Kaneko, T. Takamura

    DIABETOLOGIA 56 S182-S182 2013/09

    ISSN: 0012-186X

    eISSN: 1432-0428

  64. 脳特異的24(S)-ヒドロキシコレステロールにより誘導されるプログラムネクローシスおよび細胞保護作用の分子メカニズム

    斎藤 芳郎, 山中 一哲, 浦野 泰臣, 野口 範子

    脂質生化学研究 55 9-9 2013/05/28

    ISSN: 0285-1520

  65. インスリン抵抗性誘導ヘパトカインセレノプロテインPによる高血糖発症予知に関する検討

    御簾 博文, 田中 睦, 斎藤 芳郎, 竹下 有美枝, 喜多 裕樹, 中源 雅俊, 長野 亨, 金子 周一, 篁 俊成

    糖尿病 56 (Suppl.1) S-118 2013/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  66. Novel insights of brain-specific produced oxysterol in neurodegenerative diseases

    NOGUCHI Noriko, YAMANAKA Kazunori, TAKABE Wakako, URANO Yasuomi, SAITO Yoshiro

    日本生化学会大会(Web) 86th 2013

  67. パーキンソン病におけるバイオマーカーの現状—マイケルJフォックス財団の取り組み

    斎藤芳郎

    ファルマシア 49 (9) 870-872 2013

    Publisher: 公益社団法人 日本薬学会

    DOI: 10.14894/faruawpsj.49.9_870  

    ISSN: 0014-8601

  68. 2-IV-13 セレン欠乏に伴う酸化ストレス障害に対するビタミンEの効果 : SBP2遺伝子異常に対する治療への応用(一般演題要旨,第65回大会講演要旨)

    斎藤 芳郎, 七里 元督, 濱島 崇, 萩原 義久, 吉田 康一, 野口 範子

    ビタミン 87 (4) 2013

    Publisher: 公益社団法人 日本ビタミン学会

    ISSN: 0006-386X

  69. パーキンソン病における酸化型DJ-1測定とMIBG心筋シンチグラフィーの関連について

    西郷 和真, 斎藤 芳郎, 池上 郁子, 細井 幸子, 高田 和男, 宮本 勝一, 三井 良之, 楠 進, 野口 範子

    臨床神経学 52 (12) 1428-1428 2012/12

    Publisher: (一社)日本神経学会

    ISSN: 0009-918X

    eISSN: 1882-0654

  70. G020021 Reduction of Vitamin E radical in Electron-beam-irradiated dl-α-Tocopherol-blended Ultra High Molecular Weight Polyethylene

    Iwade H, Kawasaki T, Tajima K, Sakurai Y, Noguchi N, Saito Y, Uetsuki K, Tomita N

    Mechanical Engineering Congress, Japan 2012 "G020021-1"-"G020021-4" 2012/09/09

    Publisher: The Japan Society of Mechanical Engineers

    More details Close

    Electron-beam irradiated Vitamin E-blended Ultra-High Molecular Weight Polyehylene (UHMWPE) has been studied as a bearing material for use in hip prosthesis. Although radiation crosslinking has been successful in decreasing wear volume, Vitamin E radicals are formed during radiation crosslinking of Vitamin E-blended UHMWPE and it is hypothesized that these Vitamin E radicals may negatively impact the materials biological activity In this study, ascorbic acid 6-palmitate (lipophilic vitamin C) was applied to electron-beam-irradiated Vitamin E-blended UHMWPE in an attempt to reduce the Vitamin E radicals UHMWPE resin powder was mixed with Vitamin E at 0.3 wt% and molded under direct compression at 25MPa and 220℃ Cylindrical pins (length: 40mm, diameter: 3.5mm) were then machined from these bulk samples, packaged in a vacuum, and irradiated by electron-beam at 300kGy. Samples were subsequently doped with either ascorbic acid 6-palmitate or ethanol and subjected to a hydrostatic pressure of 100MPa for 7, 14, and 21 days at room temperature. Electron Spin Resonance (ESR) was used to measure the radicals in samples. The observed characteristic ESR peak for Vitamin E radicals was shown to decrease with time in the electron-beam-irradiated Vitamin E-blended UHMWPE samples that were doped with ascorbic acid 6-palmitate While due to the fact that Vitamin E radicals in UHMWPE have been shown to be stable at room temperature, it is thought that the observed reduction in number of VE radicals is a result of the direct action ascorbic acid 6-palmitate.

  71. レドックス制御研究の最先端 抗酸化ヘパトカインセレノプロテインPによる運動療法抵抗性の発症

    御簾 博文, 篁 俊成, 斎藤 芳郎, 高橋 和彦, 金子 周一

    日本薬学会年会要旨集 132年会 (1) 107-107 2012/03

    Publisher: (公社)日本薬学会

    ISSN: 0918-9823

  72. トコフェロール・トコトリエノールによる抗酸化作用を介した神経保護効果

    斎藤芳郎, 二木悦雄, 野口範子

    ビタミンE研究の進歩 15 73-79 2012

  73. 早期パーキンソン病患者の赤血球におけるDJ‐1の酸化

    斎藤芳郎, 浜窪隆雄, 下濱俊, 二木鋭雄, 野口範子

    日本酸化ストレス学会学術集会プログラム・抄録集 64th 60 2011/06/27

  74. パーキンソン病における新たなバイオマーカーとしての酸化型DJ‐1測定の可能性

    西郷和真, 斎藤芳郎, 三井良之, 楠進, 野口範子

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集 5th 92 2011

  75. Correlation between saliva cortisol concentration and sympathovagal balance before sleep in young male subjects.

    Yoshino Kohzoh, Saito Yoshiro, Jitousyo Mamiko, Yoshida Yasukazu

    Stress Science Research 26 48-52 2011

    Publisher: 公益財団法人 パブリックヘルスリサーチセンター

    DOI: 10.5058/stresskagakukenkyu.26.48  

    ISSN: 1341-9986

    More details Close

    The aim of this study is to investigate the correlation between saliva cortisol concentration and balance of autonomic nervous system (sympathovagal balance) before sleep in normal male subjects. The subjects (N=27) intermittently wore an ambulatory wearable device that records heart rate variability (RR-interval) for three days during daily life. Their saliva was sampled at each night before sleep. The cortisol concentration of each sample was quantified. The sympathovagal balance was evaluated by calculating the normalized high-frequency power (HFnu) of RR-interval variability that was measured from A+5 to A minutes (A=0, 5,..., 55) before the saliva sampling time. The correlation coefficients between high values of saliva cortisol concentration and the corresponding natural logarithm of HFnu were from -0.40 to -0.49 (p=0.006-0.034) when the values of A were 10, 15, 20, and 25. This result implies that hypothalamic-pituitary-adrenal (HPA) axis activity before sleep is significantly correlated with dominance of sympathetic nervous system activity with time lag of 10-30 minutes during relatively high stress condition.&lt;br&gt;

  76. Significance of translocation of coenzyme Q10 to mitochondria in its whitening and anti-aging effects

    斎藤 芳郎

    Cosmetology 19 66-69 2011

    Publisher: コスメトロジー研究振興財団

  77. 脂質酸化物により誘導される適応反応のメカニズム

    斎藤 芳郎

    放射線生物研究 45 (2) 160-169 2010/06

    Publisher: 放射線生物研究会

    ISSN: 0441-747X

  78. 新規糖尿病関連ヘパトカインセレノプロテインPの血管新生抑制作用に関する検討

    御簾 博文, 石倉 和秀, 熊崎 雅史, 林 寛人, 山田 賢裕, 高倉 伸幸, 斎藤 芳郎, 高橋 和彦, 金子 周一, 篁 俊成

    糖尿病 53 (Suppl.1) S-95 2010/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

  79. 24(S)-Hydroxycholesterol Induces SH-SY5Y Cell Death via Necroptosis, Programmed Necrosis

    Kazunori Yamanaka, Yoshiro Saito, Tohru Yamamori, Yasuomi Urano, Noriko Noguchi

    FREE RADICAL BIOLOGY AND MEDICINE 49 S137-S137 2010

    DOI: 10.1016/j.freeradbiomed.2010.10.382  

    ISSN: 0891-5849

  80. Cytoprotective Effect of Vitamin E Homologues Against Glutamate-induced Cell Death in Immature Primary Cortical Neuron Cultures: Tocopherols and Tocotrienols Exert Similar Effects by Antioxidant Function

    Yoshiro Saito, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 49 S196-S196 2010

    DOI: 10.1016/j.freeradbiomed.2010.10.567  

    ISSN: 0891-5849

  81. Elevation of Oxidized DJ-1 in the Erythrocytes of Parkinson Disease Patients and Animal Models

    Yoshiro Saito, Yoko O. Akazawa, Takao Hamakuho, Yasukazu Yoshida, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 49 S171-S171 2010

    DOI: 10.1016/j.freeradbiomed.2010.10.485  

    ISSN: 0891-5849

  82. グルタミン酸誘導性の神経細胞死に対するビタミンE類の抑制効果

    斎藤芳郎, 西尾敬子, 赤澤(小川)陽子, 吉田康一, 野口範子, 二木鋭雄

    ビタミンE研究の進歩 14 27-32 2010

  83. 3.24(S)-HyDroxycholesterolによる神経細胞死の誘導メカニズム(第327回会議研究発表要旨,脂溶性ビタミン総合研究委員会)

    野口 範子, 山中 哲一, 斉藤 芳郎, 浦野 泰臣

    ビタミン 84 (9) 448-448 2010

    Publisher: 公益社団法人 日本ビタミン学会

    DOI: 10.20632/vso.84.9_448  

    ISSN: 0006-386X

  84. 翻訳されうる21番目のアミノ酸、セレノシステインを含有するタンパク質研究のブレーク・スルー 新規インスリン抵抗性誘導ヘパトカインセレノプロテインPの同定 セレン含有タンパクによる糖代謝悪化の可能性

    御簾 博文, 高山 浩昭, 林 寛人, 斎藤 芳郎, 高橋 和彦, 篁 俊成

    日本生化学会大会プログラム・講演要旨集 82回 2S8a-5 2009/09

    Publisher: (公社)日本生化学会

  85. 24S-hydroxycholesterol による神経細胞傷害メカニズムの解析

    山中 一哲, 斎藤 芳郎, 山盛 徹, 浦野 泰臣, 野口 範子

    脂質生化学研究 51 69-72 2009/07/10

    ISSN: 0285-1520

  86. 新規ヘパトカインセレノプロテインPを介した肝臓-脂肪組織ネットワーク

    石倉 和秀, 御簾 博文, 杉森 慎, 磯部 優希, 清水 暁子, 栗田 征一郎, 竹下 有美枝, 斎藤 芳郎, 高橋 和彦, 金子 周一, 篁 俊成

    糖尿病 52 (Suppl.1) S-161 2009/04

    Publisher: (一社)日本糖尿病学会

    ISSN: 0021-437X

    eISSN: 1881-588X

  87. 酸化DJ-1とパーキンソン病(1):抗体作成とELISA開発

    斎藤芳郎, 斎藤芳郎, 浜窪隆雄, 吉田康一, 小川陽子, 岩成宏子, 望月康弘, 七里元督, 西尾敬子, 絹見朋也, 野口範子, 児玉龍彦, 二木鋭雄

    日本酸化ストレス学会学術集会プログラム・抄録集 62nd 2009

  88. 酸化DJ-1とパーキンソン病(2):臨床検体の測定

    小川陽子, 斎藤芳郎, 浜窪隆雄, 児玉龍彦, 原保夫, 藤村晴俊, 今井康陽, 岩成宏子, 七里元督, 西尾敬子, 野口範子, 吉田康一, 二木鋭雄

    日本酸化ストレス学会学術集会プログラム・抄録集 62nd 2009

  89. Significant Elevation of Oxidized DJ-1 in Erythrocytes of Early-Stage Parkinson Disease Patients: Potential Application of Oxidized DJ-1 Levels for Diagnosis of PD at Early Stage

    Yoshiro Saito, Takao Hamakuba, Yasukazu Yoshida, Yoko Ogawa Akazawa, Mototado Shichiri, Noriko Noguchi, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 47 S80-S80 2009

    ISSN: 0891-5849

  90. 血漿セレン含有蛋白質セレノプロテインPに関する最近の話題

    斎藤 芳郎

    ビタミン 83 662-665 2009

    DOI: 10.20632/vso.83.12_662  

  91. Recent topics about selenium-containing extracellular protein selenoprotein P

    Saito Yoshiro

    vitamins 83 (12) 662-665 2009

    Publisher: 公益社団法人 日本ビタミン学会

    DOI: 10.20632/vso.83.12_662  

    ISSN: 0006-386X

  92. 2-III-19 γ-トコフェリルキノンは細胞内レドックスシグナルの亢進により適応応答を誘導する(一般研究発表,日本ビタミン学会第61回大会研究発表要旨)

    小川 陽子, 斎藤 芳郎, 西尾 敬子, 吉田 康一, 二木 鋭雄

    ビタミン 83 (4) 217-217 2009

    Publisher: 公益社団法人 日本ビタミン学会

    ISSN: 0006-386X

  93. バイオマーカーとしての脂質酸化物

    吉田 康一, 今井 康陽, 澤井 良之, 吉川 敦, 斎藤 芳郎, 早川 三恵子, 羽渕 洋子, 二木 鋭雄

    脂質生化学研究 50 21-21 2008/06/05

    ISSN: 0285-1520

  94. リポ多糖(LPS)により誘導される適応反応・酸化ストレス耐性メカニズムの解析

    斎藤芳郎, 小俣葉, 藤田克英, 吉田康一, 野口範子, 二木鋭雄

    生化学 4P-0442 2008

    ISSN: 0037-1017

  95. ストレスに対する生体の応答 蛋白質

    斎藤 芳郎

    ストレスの科学と健康 52-59 2007

  96. 2-IV-15 トコフェリルキノンにより誘導される酸化ストレス耐性の応答メカニズム(ビタミン学の原点・栄養学への21世紀的回帰, 日本ビタミン学会第59回大会)

    小川 陽子, 斎藤 芳郎, 西尾 敬子, 吉田 康一, 二木 鋭雄

    ビタミン 81 (4) 186-186 2007

    Publisher: 公益社団法人 日本ビタミン学会

    ISSN: 0006-386X

  97. Antioxidant Function of essential trace element "selenium"

    SAITO Yoshiro

    バイオサイエンスとインダストリー = Bioscience & industry 64 (64) 159-160 2006/03/01

    ISSN: 0914-8981

  98. Molecular mechanisms of 6-hydroxydopamine-induced neurotoxicity

    Yoshiro Saito, Keiko Nishio, Yoko Ogawa, Tomoya Kinumi, Yasukazu Yoshida, Yoshinori Masuo, Etsuo Niki

    FREE RADICAL BIOLOGY AND MEDICINE 41 S168-S168 2006

    ISSN: 0891-5849

  99. Environmental stress and apoptosis

    Yoshinori Mastro, Yoshiro Saito, Yasukazu Yoshida, Etsuo Niki

    NEUROSCIENCE RESEARCH 55 S40-S40 2006

    ISSN: 0168-0102

  100. 抗酸化蛋白質DJ-1の酸化修飾による機能制御

    斎藤 芳郎

    蛋白質の翻訳後修飾と疾患プロテオミクス 34-40 2006

  101. A turning point to apoptotic and necrotic cell death induced by hydrogen peroxide

    Y Saito, K Nishio, Y Ogawa, T Kinumi, Y Yoshida, N Noguchi, E Niki

    FREE RADICAL BIOLOGY AND MEDICINE 39 S147-S147 2005

    ISSN: 0891-5849

  102. 4-hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of NRF2

    ZH Chen, Y Saito, Y Yoshida, A Sekine, N Noguchi, E Niki

    FREE RADICAL BIOLOGY AND MEDICINE 39 S69-S69 2005

    ISSN: 0891-5849

  103. 必須微量元素セレン及び酸化ストレスに伴う細胞死に対するAOBの添加効果

    斎藤 芳郎

    AOB研究会 (4) 42-46 2005

  104. WS-9-07 gemcitabine耐性膵癌に対する新規治療法の検討(ワークショップ9 : 分子生物・遺伝子研究の消化器癌補助療法への応用)

    前原 伸一郎, 島田 光生, 調 憲, 田中 真二, 斎藤 芳郎, 高橋 和彦, 前原 喜彦

    日本消化器外科学会雑誌 37 (7) 1004-1004 2004/07/01

    Publisher: 一般社団法人日本消化器外科学会

    ISSN: 0386-9768

  105. 1-IV-3 ビタミンE同族体の眼球組織移行性に関する研究(第56回大会一般研究発表)

    吉田 康一, 戸谷 正樹, 伊藤 奈々子, 斎藤 芳郎, 大平 明弘, 二木 悦雄

    ビタミン 78 (4) 235-235 2004/04/25

    Publisher: 日本ビタミン学会

    ISSN: 0006-386X

  106. Synergistic cytotoxic effects of formaldehyde and free radicals

    Y Saito, K Nishio, Y Yoshida, E Niki

    FREE RADICAL BIOLOGY AND MEDICINE 37 S144-S144 2004

    ISSN: 0891-5849

  107. Antioxidative effects of volatile constituents of a rosemary extract on the lipid oxidation and cell damage

    A Shiga, Y Saito, T Furuhashi, J Hoshizaki, Y Fujita, Y Yoshida, E Niki

    FREE RADICAL BIOLOGY AND MEDICINE 37 S43-S43 2004

    ISSN: 0891-5849

  108. Vitamin E and BO-653: Natural vs. synthetic antioxidant

    E Niki, Y Yoshida, Y Saito, N Itoh, O Cynshi, N Noguchi, T Kodama

    FREE RADICAL BIOLOGY AND MEDICINE 36 S7-S7 2004

    ISSN: 0891-5849

  109. トコトリエノールのストレス抑制作用と細胞内取り込みについて

    斎藤 芳郎

    ビタミンE研究の進歩 (11) 108-114 2004

  110. 紫外線とNO2による酸化反応に対するローズマリー揮発成分の抑制効果

    斎藤 芳郎, 志賀 彰, 吉田 康一

    Aroma research 5 (2) 118-122 2004

    Publisher: フレグランスジャーナル社

    ISSN: 1345-4722

  111. Reduction of lipid hydroperoxides in oxidized LDL by extracellular glutathione peroxidase and selenoprotein P

    G Takebe, K Takashima, Y Saito, T Hayashi, S Nagasawa, K Takahashi

    ATHEROSCLEROSIS SUPPLEMENTS 4 (2) 286-286 2003/09

    ISSN: 1567-5688

  112. 膵癌における抗癌剤(gemcitabine)耐性規定遺伝子の同定と感受性診断への応用

    前原 伸一郎, 田中 真二, 島田 光生, 調 憲, 斎藤 芳郎, 高橋 和彦, 前原 喜彦

    日本消化器外科学会雑誌 36 (7) 871-871 2003/07/01

    Publisher: 一般社団法人日本消化器外科学会

    ISSN: 0386-9768

  113. 必須微量元素セレンの細胞生存維持作用に関する研究

    斎藤 芳郎, 吉田 康一, 二木 鋭雄, 高橋 和彦

    脂質生化学研究 45 262-265 2003/06/20

    ISSN: 0285-1520

  114. 抗癌剤gemcitabine感受性規定遺伝子の網羅的解析による治療指標の同定

    前原 伸一郎, 島田 光生, 調 憲, 田中 真二, 斎藤 芳郎, 高橋 和彦, 前原 喜彦

    日本外科学会雑誌 104 (0) 286-286 2003/04/30

    Publisher: 一般社団法人日本外科学会

    ISSN: 0301-4894

  115. Antioxidant action of vitamin E isoforms

    E Niki, Y Yoshida, Y Saito, R Piga, N Noguchi

    FREE RADICAL RESEARCH 37 40-40 2003

    ISSN: 1071-5762

  116. Cell death caused by selenium deficiency and protective effect of antioxidants

    Y Saito, Y Yoshida, K Takahashi, E Niki

    FREE RADICAL BIOLOGY AND MEDICINE 35 S46-S46 2003

    ISSN: 0891-5849

  117. Reduction of hydroperoxides in oxLDL and inhibition of oxLDL formation by extracellular selenium-containing antioxidant enzymes

    G Takebe, K Takashima, Y Saito, T Hayashi, K Takahashi

    FREE RADICAL BIOLOGY AND MEDICINE 33 S145-S146 2002

    ISSN: 0891-5849

  118. Characterization of selenoprotein P as a selenium transport protein

    Y Saito, E Niki, K Takahashi

    FREE RADICAL BIOLOGY AND MEDICINE 33 S92-S92 2002

    ISSN: 0891-5849

  119. 血漿セレン含有蛋白質Selenoprotein Pのユニークな構造とその機能

    斎藤 芳郎

    放射線生物研究 36 (36) 291-301 2001/09

    Publisher: 放射線生物研究会

    ISSN: 0441-747X

  120. Glutathione peroxidase family の酸化LDL産生に及ぼす影響

    建部 厳, 高嶋 和巳, 斎藤 芳郎, 高橋 和彦, 林 隆章

    脂質生化学研究 43 311-313 2001/05/10

    ISSN: 0285-1520

  121. Structure and function of human selenoprotein P

    TAKAHASHI Kazuhiko, SAITO Yoshiro

    生化學 73 (73) 261-264 2001/04/25

    Publisher: 日本生化学会

    ISSN: 0037-1017

  122. Structure and function of human selenoprotein P

    K. Takahashi, Y. Saito

    Seikagaku 73 (4) 261-264 2001

    ISSN: 0037-1017

  123. 全く異なる2つの顔を持つ蛋白質

    斎藤 芳郎

    ファルマシア (36) 513-514 2000

  124. 全く異なる2つの顔を持つタンパク質

    斎藤 芳郎

    ファルマシア 36 (6) 513-514 2000

    Publisher: 公益社団法人 日本薬学会

    ISSN: 0014-8601

  125. Selenoprotein P as an extracellular phospholipid hydroperoxide glutathione peroxidase

    Y Saito, T Hayashi, A Tanaka, M Suzuki, E Saito, K Takahashi

    FREE RADICAL BIOLOGY AND MEDICINE 25 S38-S38 1998

    ISSN: 0891-5849

  126. ヒト血漿セレン含有蛋白質SePの精製と構造解析

    斎藤 芳郎, 西村 仁, 高橋 和彦

    日本分子生物学会年会プログラム・講演要旨集 19 490-490 1996/08/01

Show all ︎Show first 5

Books and Other Publications 8

  1. 神経変性とレドックスーパーキンソン病関連分子DJ-1のレドックス制御機能 レドックスUPDATE

    医歯薬出版 2015

  2. パーキンソン病と酸化ストレス 酸化ストレスの医学 第2版

    診断と治療社 2014

  3. グルタミン酸誘導性の神経細胞死に対するビタミンE類の抑制効果

    ビタミンE研究の進歩 2010

  4. Cytoprotective effects of vitamin E homologues against glutamate-induced neuronal cell death

    Progress of vitamin E research 2010

  5. A Gene Expression Profiling Approach to Study the Influence of Ultrafine Particles on Rat Lungs.

    Atmospheric and Biological Environmental Monitoring 2009

  6. A Gene Expression Profiling Approach to Study the Influence of Ultrafine Particles on Rat Lungs.

    Atmospheric and Biological Environmental Monitoring 2009

  7. Uptake, Distribution and Protective Action of Tocotrienols in Cultured Cells.

    Tocotrienols : Vitamin E Beyond Tocopherols 2008

  8. Uptake, Distribution and Protective Action of Tocotrienols in Cultured Cells.

    Tocotrienols : Vitamin E Beyond Tocopherols 2008

Show all Show first 5

Presentations 2

  1. Novel Method for Suppression of Neuronal Cell Death by 24S-Hydroxycholesterol

    野口 範子, 斎藤 芳郎, 浦野 泰臣

    同志社大学理工学研究報告 2015/01

  2. 新規糖尿病バイオマーカーを標的とする2型糖尿病治療薬

    イノベーション・ジャパン2013 2013

Industrial Property Rights 27

  1. セレノプロテインPの発現抑制剤及びその利用

    斎藤 芳郎, 三田 雄一郎, 野口 範子, 内田 理沙, 安原 小百合, 横大路 将, 白川 静乃

    Property Type: Patent

  2. 2型糖尿病患者の治療薬選択の補助方法、治療薬の効果予測方法、検査方法及び治療方法

    御簾 博文, 金子 周一, 竹下 有美枝, 篁 俊成, 斎藤 芳郎, 田中 睦

    Property Type: Patent

  3. 2型糖尿病の治療及び/又は予防薬

    斎藤 芳郎, 野口 範子, 三田 雄一郎, 中山 華穂

    Property Type: Patent

    More details Close

    特願2013-175612

  4. 細胞死抑制剤

    浦野 泰臣, 野口 範子, 斎藤 芳郎, 山中 一哲

    Property Type: Patent

  5. 細胞死抑制剤

    浦野 泰臣, 野口 範子, 斎藤 芳郎, 山中 一哲

    特許第6143435号

    Property Type: Patent

    More details Close

    特願2012-242950

  6. 被測定物質の分別測定方法

    田中 睦, 斎藤 芳郎

    Property Type: Patent

    More details Close

    特願2012-198464

  7. 含硫アミノ酸残基を含むポリペプチドに対する抗体

    斎藤 芳郎, 野口 範子, 浜窪 隆雄, 岩成 宏子, 二木 鋭雄, 吉田 康一, 新井 修

    Property Type: Patent

  8. 含硫アミノ酸残基を含むポリペプチドに対する抗体

    斎藤 芳郎, 野口 範子, 浜窪 隆雄, 岩成 宏子, 二木 鋭雄, 吉田 康一, 新井 修

    特許第5885158号

    Property Type: Patent

    More details Close

    特願2012-028138

  9. 過酸化脂質の測定方法

    斎藤 芳郎, 野口 範子, 山中 一哲, 崎▼山 順次, 大瀬戸 文夫

    Property Type: Patent

    More details Close

    特願2011-260819

  10. 生体の抗酸化能測定方法

    斎藤 芳郎, 野口 範子, 澤田 浩隆

    Property Type: Patent

    More details Close

    特願2011-181963

  11. 含硫アミノ酸残基が酸化された酸化型ポリペプチドに対する抗体

    吉田 康一, 斎藤 芳郎, 小川 陽子, 二木 鋭雄, 七里 元督, 浜窪 隆雄, 望月 康弘, 岩成 宏子, 細見 直樹

    Property Type: Patent

    More details Close

    特願2009-028042

  12. 酸化傷害抑制剤

    斎藤 芳郎, 二木 鋭雄, 吉田 康一, 加藤 久豊, 山口 修平

    Property Type: Patent

    More details Close

    特願2008-100401

  13. ペルオキシレドキシン6(Prx6)に対するアプタマー

    御園 智子, ペンメッチャ クマール, 斎藤 芳郎, 吉田 康一

    Property Type: Patent

  14. ペルオキシレドキシン6(Prx6)に対するアプタマー

    御園 智子, ペンメッチャ クマール, 斎藤 芳郎, 吉田 康一

    特許第5083892号

    Property Type: Patent

  15. HCV患者における瀉血治療の効果の検査方法

    吉田 康一, 斎藤 芳郎, 二木 鋭雄, 今井 康陽, 澤井 良之

    特許第5177630号

    Property Type: Patent

  16. HCV患者における瀉血治療の効果の判定方法及び判定キット

    吉田 康一, 斎藤 芳郎, 二木 鋭雄, 今井 康陽, 澤井 良之

    Property Type: Patent

    More details Close

    特願2007-252895

  17. 含硫アミノ酸残基が酸化された酸化型ポリペプチドの製造方法

    斎藤 芳郎, 絹見 朋也, 西尾 敬子, 小川 陽子, 吉田 康一, 二木 鋭雄

    Property Type: Patent

  18. 含硫アミノ酸残基が酸化された酸化型ポリペプチドの製造方法

    斎藤 芳郎, 絹見 朋也, 西尾 敬子, 小川 陽子, 吉田 康一, 二木 鋭雄

    特許第4779103号

    Property Type: Patent

    More details Close

    特願2006-153039

  19. ウイルス性肝疾患の診断方法及び診断キット

    吉田 康一, 斎藤 芳郎, 二木 鋭雄, 今井 康陽, 澤井 良之

    Property Type: Patent

  20. C型肝炎ウイルスに起因する慢性肝炎及び肝硬変の指標とするための方法及びキット

    吉田 康一, 斎藤 芳郎, 二木 鋭雄, 今井 康陽, 澤井 良之

    特許第4569959号

    Property Type: Patent

    More details Close

    特許第4569959号

  21. ラジカルを含む殺菌性材料

    斎藤 芳郎, 吉田 康一, 二木 鋭雄, 民谷 栄一, 羽柴 智彦, 川村 幸嗣

    Property Type: Patent

    More details Close

    特願2004-126525

  22. メタノール、エタノールまたはホルムアルデヒドに由来する活性種を含む処理ガスのインジケーター

    吉田 康一, 二木 鋭雄, 斎藤 芳郎, 民谷 栄一, 羽柴 智彦, 川村 幸嗣

    Property Type: Patent

    More details Close

    特願2003-349980

  23. 抗酸化剤放出装置および抗酸化剤放出方法

    志賀 彰, 古橋 拓也, 藤田 洋司, 牧野 浩招, 鈴木 聡, 斎藤 芳郎, 吉田 康一, 二木 鋭雄

    Property Type: Patent

    More details Close

    特願2003-345543

  24. アスベストの除去装置

    古賀 基之, 斎藤 芳郎

    特許第2707276号

    Property Type: Patent

  25. 2型糖尿病患者の治療薬選択の補助方法、治療薬の効果予測方法及び検査方法

    Property Type: Patent

    More details Close

    特願2014-184499

  26. ペルオキシレドキシン6(Prx6)タンパク質の検出方法

    Property Type: Patent

    More details Close

    特願2008-006123

  27. ウィルス性肝疾患の診断方法及び診断キット

    Property Type: Patent

    More details Close

    特願2005-174962

Show all Show first 5

Research Projects 21

  1. Global Exploration for Redox Supermolecules Evolving in Life Functions

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Fund for the Promotion of Joint International Research (International Leading Research )

    Institution: Tohoku University

    2023/11/17 - 2030/03/31

  2. Elucidation of the molecular pathology of chronic diseases and establishment of new treatment methods based on trace element research

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2024/04/01 - 2028/03/31

  3. The regulation mechanism of oxidation and hypersulfidation in increase of effects of exercise for diabetes prevention

    Offer Organization: JST

    System: KAKENHI

    Category: B

    Institution: Doshisha University

    2024/04 - 2027/03

  4. Elucidation of the direct metabolic control mechanisms of producing cells by secreted proteins

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Research (Exploratory)

    Institution: Tohoku University

    2024/06/28 - 2026/03/31

  5. Regulation of signal transduction via crosstalk between supersulfide and selenium

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Transformative Research Areas (A)

    Institution: Tohoku University

    2021/09/10 - 2026/03/31

  6. Management of international relation and facility for promotion of research on sulfur biology

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Transformative Research Areas (A)

    Institution: Tohoku University

    2021/09/10 - 2026/03/31

  7. The Blood Diagnostic Markers in Dementia with Lewy Bodies

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: Kindai University

    2022/04/01 - 2025/03/31

  8. Regulatory mechanism of selenoprotein P expression and its deterioration mechanism of glucose metabolism

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A)

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2020/04/01 - 2024/03/31

  9. Creation of "disease metallomics" to understand the relationship between fluctuations of heavy metals/trace elements and diseases

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Research (Exploratory)

    Institution: Tohoku University

    2021/07/09 - 2023/03/31

  10. Elucidation of a dynamics control mechanism of selenium

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

    Category: Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

    Institution: Tohoku University

    2020/04/01 - 2022/03/31

  11. Fatigue assessment and analysis of trace element deficiency and eating habits survey for prevention of mental health disorder of university students

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: Koshien University

    2019/04/01 - 2022/03/31

  12. Omics analysis for the establishment of "reductive stress," a biological disorder caused by excessive antioxidant and reductive environment

    Saito Yoshiro

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory)

    Category: Grant-in-Aid for Challenging Research (Exploratory)

    Institution: Tohoku University

    2019/06/28 - 2021/03/31

    More details Close

    Antioxidant systems that reduce and detoxify reactive oxygen species (ROS) play an important role in maintaining cell homeostasis. However, in recent years, biological disorders induced by excessive antioxidants and reducing enzymes, namely reductive stress, have caused insulin resistance, involving in the onset and progression of type 2 diabetes. Thus, the purpose of this study is to identify the characteristic cellular response in the excessive reduction state by the comprehensive analysis and to clarify the reductive stress response at the molecular level.

  13. Molecular mechanisms of disorder of pancreatic beta cells induced by excess selenoprotein P

    Saito Yoshiro

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    2017/04/01 - 2020/03/31

    More details Close

    Selenoprotein P (SeP), a plasma protein containing essential trace element selenium, functions as a transporter of selenium, delivering selenium to the cells. We found the increase of SeP levels in type 2 diabetes patients and have reported that increased SeP (excess SeP) worsen glucose metabolism via the increase of insulin resistance in the skeletal muscle and liver. In the present study, we found that excess SeP is incorporated into the pancreatic beta cells via SeP receptors and decreases insulin secretion via ER stress. Furthermore, we found the physiological role of SeP expression in the pancreatic beta cells and stated the novel metabolism regulation between the pancreas and liver via insulin and SeP.

  14. Mechanism of inhibition of oxysterol-induced Alzheimer's disease by vitamin E

    Noguchi Noriko

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: Doshisha University

    2016/04/01 - 2019/03/31

    More details Close

    While 24(S)-hydroxycholesterol(24S-OHC)plays an important role in cholesterol metabolism in the brain, its contribution in pathogenesis of Alzheimer’s disease (AD) has received attention. 24S-OHC was esterified by action of the enzyme at endoplasmic reticulum (ER) and caused formation of lipid droplet-like structure and disruption of ER membrane integrity, resulting in release of ER chaperones into cytosol. Vitamin homologues are divided into two group, tocotrienol (Toc3) and tocopherol (Toc), with and without double bonds at their side chain. The chaperone release and cell death induced by 24S-OHC were inhibited by Toc but not by Toc3. The critical effect of the side chain of vitamin E on ER membrane integrity and 24S-OHC-induced cell death was indicated.

  15. Selenium-transport mechanism of selenoprotein P

    Saito Yoshiro, NOGUCHI Noriko, TAKAHASHI Kazuhiko

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Doshisha University

    2013/04/01 - 2017/03/31

    More details Close

    Selenoprotein P (SeP) is plasma selenoprotein containing essential trace element selenium. SeP functions as a transporter of selenium, delivering selenium to the cells. However, details of selenium-transport mechanisms of SeP remain unknown. In the present study, we identified SeP receptors in several tissues such as skeletal muscle, pancreas, and lymphocytes. Further, we identified SeP receptors with different affinity for SeP, and found a different molecular pathway to transport selenium of SeP to the cells. Collectively, we revealed selenium-transport mechanisms of SeP.

  16. Development of diagnosis and treatment of Parkinson disease at early stage using novel biomarker oxidized DJ-1

    Yoshiro Saito, NOGUCHI Noriko, SAIGOH Kazumasa

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research

    Category: Grant-in-Aid for Challenging Exploratory Research

    Institution: Doshisha University

    2013/04/01 - 2016/03/31

    More details Close

    DJ-1, the product of the causative gene of a familial form of Parkinson’s disease (PD), undergoes preferential oxidation at the cysteine residue at position 106 (Cys-106) under oxidative stress. In the present study using specific antibodies against Cys-106-oxidized DJ-1 (oxDJ-1), we evaluated oxDJ-1 levels in brain and blood of PD patients. It was found that DJ-1 oxidation in erythrocytes and in the brain occurs in PD patients, particularly during the early phases. DJ-1 oxidation was effectively inhibited by endogenous antioxidant glutathione. We could develop the molecular base for the diagnosis and treatment of PD at early phases based on the levels of oxDJ-1.

  17. The study on functional food using oxidative stress marker, hydroxyoctadecadienoic acid and 7-hydroxycholesterol

    YOSHIDA Yasukazu, NIKI Etsuo, AKAZAWA Yoko, SAITO Yoshiro

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: National Institute of Advanced Industrial Science and Technology

    2007 - 2009

    More details Close

    Lipid peroxidation products have received a great deal of attention for the partical application to clinical use as bio-markers. To assess the antioxidative role of functional foods and antioxidants, vitamin E and BO-653, in a mouse model and culture cell using lipid peroxidation and protein oxidation products. In the present study, we proposed that lipid peroxidation (tHODE and tOHCh) and protein oxidation are indeed good markers for the detection of progression of oxidative stress and effect of functional foods.

  18. 培養神経細胞および幼若ラット脳を用いたドーパミン神経障害メカニズムの探究

    斎藤 芳郎

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 若手研究(B)

    Category: 若手研究(B)

    Institution: 独立行政法人産業技術総合研究所

    2006 - 2007

    More details Close

    本研究の目的は,6ーヒドロシドーパミン1-methy1-4-pheny-1,2,3,6-tetrahydropyridine(MPTP)など汎用されているドーパミン神経毒の作用について,ガン細胞,初代培養細胞および幼若ラット洋悩を用いて,in vitroおよびin vivoでの角析を同時に行い,その細胞障害メカニズムを明らかにすることにある。今年度は,ガン細胞である12細胞だけでなく,初代神経細胞においても15d-PGJ2や4-HNEなどの細胞毒性をもつアルデヒドが,神経細胞の適応応答を介して,6-OHDAやグルタミン酸による神経細胞死を抑制することを明らかにした(J Neurochemistry,102,1625-1634)。さらに,アリル化しうるキノンであるγ-トコフェリルキノンが,同様にガン細胞・初代神経細胞ともに適応反応を誘導することがわかった(現在投稿中)。これらは,細胞内のGSHを増加して、適応反応を誘導することがわかった。アルデヒド類はNrf2依存的に、グルタミン酸システインリガーゼの修飾サブユニットを誘導して,グルタチオンを誘導した。一方,γ-トコフェリキノンは,シスチンの取り込みを担うxCT,ATF4依存的に誘導することが明らかとなった。これらの適応反応およびGSHの増加は,各転写因子に対するsiRNA処理で,低下あるいは消失した。これらの適応反応に関する知見は,神経変性疾患の発症や進展に関与する可能性が考えられ,新たな創薬のヒントをいだす知見である。さらに,p-キノンにより誘導される神経細胞死メカニズムについては幼若ラット脳のプロテオーム解析からp-キノンで特異的に変化する分子を見いだしている。これらを同定し,初代培養系および幼若ラットで比較検討中である。

  19. 酸化血清中に存在する細胞傷害因子の探索-新規酸化ストレスマーカーの同定を目指して

    斎藤 芳郎

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 若手研究(B)

    Category: 若手研究(B)

    Institution: 独立行政法人産業技術総合研究所

    2004 - 2005

    More details Close

    1.酸化血清中の血管細胞増殖因子の同定 前年度の結果から、酸化血清中に含まれる過酸化脂質が主要な血管細胞増殖因子として機能する可能性が考えられた。このことを証明するため、脂質を除去した血清(Lipoprotein Deficient Serum以下LPDS)を作成し検討した。 ヒト血清にKBrを加え、超遠心を行い、上層にリポタンパク質画分を、下層にLPDS画分を得た。透析して得られたLPDSをラジカル酸化剤を用いて酸化し、酸化LPDSを作成し、AKTAクロマトグラフィーを用いてゲルろ過で分離した。分離したフラクションを、前年度確立したバイオアッセイ系で評価した。48穴プレートに、ヒト動脈内皮細胞(HAEC)やヒト動脈平滑筋細胞(AoSMC)などのヒト由来血管細胞を播種し、分離したフラクションをくわえた。各画分を添加して、24〜72時間培養後、生細胞数をMTT法を用いて測定した。その結果、高分子画分に認められた増殖因子が消失した。さらに、低比重リポタンパク質(LDL)を同様に酸化し、得られた酸化LDLを血管細胞に添加した結果、類似の細胞増殖が認められた。以上の結果から、酸化血清中の主要な細胞増殖因子は、酸化LDLに由来することがわかった。酸化ストレスと動脈硬化との関係において、重要な知見が得られた。酸化LDLの測定系に関しは、当ヒューマンストレスシグナル研究センターの酸化脂質ストレスマーカーtHODE、t7-OHChとの相関性について検討を行っている。また、これまで我々の研究室で認められた酸化LDL添加により当電点が変化するタンパク質の解析を行っている。 2.接着分子の発現に及ぼす影響 さらに、酸化血清の作用について、細胞表面への接着分子の発現に及ぼす影響について解析した。方法は同一で、得られた酸化血清フラクションを血管細胞に添加後、フローサイトメーターを用いて接着分子の発現量を定量した。その結果、生細胞数への影響とは異なるとこにピークが認められた。今後、この分子の同定を行っていきたい。

  20. 血漿セレン含有タンパク質セレノプロテインPの機能と生理的意義の解析

    斎藤 芳郎

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 特別研究員奨励費

    Category: 特別研究員奨励費

    Institution: 北海道大学

    2000 - 2001

  21. 活性酸素種による適応反応のメカニズム Competitive

Show all Show first 5

Social Activities 9

  1. 東北大学学友会アメフト部ホーネッツ部長

    2022/04/01 - Present

  2. レドックス ウィーク イン 仙台 2025 一般公開講座

    2025/04/20 - 2025/04/20

  3. フォーラム2024 衛生薬学・環境トキシコロジー 若手研究者の会 若手研究者のための勉強会「科研費申請書の書き方講座」

    2024/09/04 - 2024/09/04

  4. 秋田県立秋田高校 出前授業

    秋田県立秋田高校 出前授業

    2024/05/29 - 2024/05/29

  5. 山形県立米沢興譲館高等学校 出前授業

    2022/10/03 - 2022/10/03

  6. 東北大学進学説明会

    2022/07/03 - 2022/07/03

  7. 弘前高校 出前授業

    2020/10/26 - 2020/10/26

  8. 古川高校小講演会

    2019/09/17 - 2019/09/17

  9. 東北大学サイエンスカフェ

    2019/07/12 - 2019/07/12

Show all Show first 5

Media Coverage 5

  1. 血中濃度に性差のある元素・セレンと鉄代謝の関連性を発見-ICP-MSを用いた網羅的微量元素解析法を確立

    日本経済新聞

    2025/07

    Type: Newspaper, magazine

  2. 不安定な必須微量元素セレンの安定な生体貯蔵法 セレン欠乏に対する安定なセレン代謝利用の分子機構

    2025/05

    Type: Internet

  3. 東北大、食品成分スルフォラファンによる糖尿病増悪因子の制御を発見

    2023/11

    Type: Newspaper, magazine

  4. 東北大など、緑茶の成分に糖尿病の予防効果がある理由の一端を解明

    マイナビニュース

    2021/06

    Type: Internet

  5. 糖尿病を悪化させるSePタンパク質の合成を抑制する新規RNAを発見

    糖尿病リソースガイド

    2021/06

    Type: Internet

Academic Activities 7

  1. Redox Week in Sendai 2025, Organizing Committee

    2025/04/17 - 2025/04/21

    Activity type: Academic society, research group, etc.

  2. フォーラム2024 衛生薬学・環境トキシコロジー シンポジウム企画 レドックス超分子・活性種研究の新潮流

    2024/09/05 - 2024/09/05

    Activity type: Academic society, research group, etc.

  3. The XVIth International Congress of Toxicology(ICT2022), planning of inter national symposium, Electrophiles-induced modification and biological response- Cutting edge research on oxidative stress for toxicology

    2022/09/21 - 2022/09/21

    Activity type: Academic society, research group, etc.

  4. 第2回レドックスR&D戦略委員会 春のシンポジウム 世話人

    2022/03/04 - 2022/03/04

    Activity type: Academic society, research group, etc.

  5. STINT-JSPS Joint Symposium, Main Organizer

    2022/10/28 - 2022

    Activity type: Competition, symposium, etc.

  6. 生命金属科学 第一回領域会議 地方巡業(仙台) 世話人

    2021/01/23 - 2021/01/23

    Activity type: Competition, symposium, etc.

  7. 第31回ビタミンE研究会 世話人

    2020/01/10 - 2020/01/11

    Activity type: Academic society, research group, etc.

Show all Show first 5